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INTRODUCTION
Congenital heart disease (CHD) is reported to be the most frequent congenital cardiac 
malformation. Although reports on the incidence vary considerably from 0.4 to 5% the 
most widely accepted estimate of the incidence of congenital heart disease (CHD) is 
0.8% of all life births [1]. Of the CHD, isolated VSD is by far the most common diagnosis, 
accounting for 20% [1] to 30% of all CHD. In the Netherlands, approximately 1500 new-
borns (out of 190.000 life births) per year have a congenital cardiac malformation, of 
which approximately 30% (450) have a VSD. This is 0.3% of the living newborns (www.
nederlandsehartstichting.nl). The incidence of CHD depends mainly on the number of 
patients with a small VSD and the timing and accuracy of the diagnosis in these patients. 
As a rule of thumb it is commonly accepted that the incidence of VSD is 30-40% of all 
congenital cardiac disease and 0-8% of all living newborns. VSD is found slightly more 
frequently in females than in males (56% vs. 44%) [2]. 
In the majority of the patients with an isolated VSD (95%) the defect is not asso-
ciated with a chromosomal abnormality and the cause is unknown. A multifactorial 
aetiology has been suggested in which interaction between hereditary predisposition 
and environmental inﬂuences result in the defect [3]. An example of this hereditary pre-
disposition is the high incidence of subaortic VSDs in Japan and China; 35% versus 5% 
in Caucasians [4].
ASPECTS OF SURGICAL ANATOMY
VSDs arise from failure of growth, alignment or fusion of one or more septal components 
and are best classiﬁed according to their margins and location [5]. 
A ventricular septal defect is a cardiac anomaly consisting of a connection between 
the right ventricle and the left ventricle. These defects can be single or multiple. A VSD 
may occur in any portion of the interventricular septum, including the membranous, 
muscular, inlet, or outlet septum, or a combination of locations.
Perimembraneous VSD. This is the most common type of VSD (80%). Part of the defect 
is bordered by the ﬁbrous continuity between the mitral and tricuspid valve. The defect 
may be partially or completely occluded by the septal leaﬂet of the tricuspid valve.
Muscular VSD. This comprises 5% of VSDs and this defect is completely surrounded 
by muscular tissue. These defects are by deﬁnition located in the muscular part of the 
ventricular septum. Spontaneous closure of muscular VSDs frequently occurs in the ﬁrst 
2 years of life.
Outlet VSD. This comprises 5-10% of VSDs and part of the superior border is formed 
by the continuity between the aortic and pulmonary valves. Acquired aortic regurgita-
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tion may be caused by prolapse of (usually) the right coronary leaﬂet into the defect. 
This prolapsing leaﬂet may functionally occlude an anatomically large VSD. A higher 
incidence of outlet VSDs occurs in Asian populations (25-30%) [4, 6].
Inlet VSD. This exists in the inlet part of the septum that separates the mitral and 
tricuspid valves, under the tricuspid valve and is least frequent. These VSDs are usually 
single defects and do not close spontaneously.
PATHOPHYSIOLOGICAL MECHANISMS
Because pulmonary vascular resistance (PVR) is high at birth and may decrease as late 
as 6-8 weeks, signiﬁcant left-to-right shunting through the VSD with development of 
pulmonary overﬂow often is delayed until the second or third month of life. 
The hemodynamic signiﬁcance of a VSD is primarily determined by 2 factors: the 
size of the defect, a large VSD will allow more blood ﬂow through the defect than a 
smaller VSD, and the pulmonary vascular resistance with more blood ﬂowing across a 
VSD when the pulmonary vascular resistance is low. The diameter of the VSD in relation 
to the diameter of the aortic valve annulus may provide an indication for the size of the 
VSD. A VSD with the size of the aortic valve annulus may be regarded as large and carries 
the risk of a large left to right shunt and secondary pulmonary hypertension.
In large, non-restrictive VSDs the right and left ventricular pressures are equal. 
Due to pulmonary hypertension progressive pulmonary vascular disease will develop, 
resulting in a decrease of the degree of left-to-right shunting over time and eventually 
development of shunt reversal, from left-to-right into right-to-left shunting, leading to 
Eisenmenger physiology, when pulmonary vascular resistance exceeds systemic levels 
[7]. Nowadays this is uncommon in the western world because virtually all patients will 
have been operated upon before this stage.
In moderately restrictive VSDs, often the diameter of the defect is less than the 
diameter of the aortic annulus [7]. Both right ventricular systolic pressure and pulmo-
nary vascular resistance may be increased to some extent, but not as explicit as for the 
non-restrictive VSD. Both left atrial and ventricular dilatation due to volume overload 
may be present. The degree of left-to-right shunting is moderate to severe.
In small VSDs, the size of the defect is often less than one third of the aortic annular 
size and implicates a signiﬁcant systolic pressure gradient between the ventricles [7]. In 
these restrictive VSDs, pulmonary vascular resistance and right ventricular systolic pres-
sure will be normal and the degree of left-to-right shunting is variable.
Most adults with small VSDs can participate fully in physical activities and sport-
ing, but long-term follow-up is recommended to identify spontaneous closure, to 
Introduction 13
reinforce advice on endocarditis prophylaxis and to monitor for the onset of com-
plications.
ASPECTS OF NATURAL HISTORY
The natural history of non-operated patients diﬀers. Small defects mostly behave benign 
and have a tendency to become even less important or to close spontaneously. Patients 
with a spontaneously closed VSD and normal ventricular function probably have a nor-
mal life expectancy, as have asymptomatic adults with restrictive VSDs and normal pul-
monary vascular resistance (25-year survival rate 96%) [8]. The ﬂow across the VSD may 
have several direct and indirect deleterious eﬀects. The ﬂow from the left to the right 
ventricle results in an increased ﬂow in the pulmonary bed. This may be accompanied by 
left heart enlargement as well as a rise in left ventricular end-diastolic pressure. Symp-
toms in infants are failure to thrive, shortness of breath and excessive sweating. Arrhyth-
mias may develop on the long term, mostly atrial ﬁbrillation, and often coincides with 
a late increase in left-to-right shunting. Double chambered right ventricle may occur in 
relation to a high velocity jet through the VSD into the right ventricle [2]. 
Patients with a subarterial VSD are more prone to develop aortic regurgitation. Both 
the absence of anatomic support in some of the outlet VSDs, as well as by a Venturi 
eﬀect of the VSD jet on the aortic valve leaﬂets, may cause a prolapse of a cusp of the 
aortic valve, most often the right coronary cusp, giving rise to aortic valve regurgitation 
[9]. This injury is not necessarily related to the amount of ﬂow across the VSD. Damage to 
the aortic valve is not reversible and may have serious consequences. To prevent devel-
opment of aortic cusp prolapse and aortic regurgitation, any subarterial VSD of ≥5mm 
should be closed early [6].
Patients with a VSD are at increased risk of endocarditis. Endocarditis prophylaxis is 
widely being advised. Although rare, sudden cardiac death is also reported [8]. Patients 
with Eisenmenger physiology are rare nowadays, but have a poor long-term prognosis 
(25-year survival rate 42%) [8].
DIAGNOSIS
Most VSDs are diagnosed in infancy. Diagnosis is mostly based on physical examination. 
Congestive heart failure, failure to thrive and recurrent respiratory tract infections are the 
most frequent presenting clinical conditions. A characteristic pansystolic heart murmur 
is found. Sometimes a thrill can be felt precordially. On electrocardiogram hypertrophy 
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of the ventricles can be determined. On chest X-ray in patients with a large VSD signs of 
mild cardiac enlargement and increased pulmonary vascularity can be detected. 
Echocardiography including color Doppler, has become the gold standard in ana-
lyzing the morphologic and hemodynamic characteristics of a VSD. This means that it 
is possible to deﬁne the morphologic nature of the margins and shape of the defect. 
Other anatomic structures such as the tricuspid valve leaﬂets, the right ventricular out-
ﬂow tract, and the aortic valve can be displayed in their realistic spatial distribution. 
The shunting in relation to the size of the defect can also be estimated by assessing the 
diameter of the defect and the ﬂow signal across it [10]. 
INDICATIONS AND APPROACH FOR SURGERY
The majority of isolated congenital VSDs close spontaneously. Small muscular and small 
perimembranous VSDs may close spontaneously in the ﬁrst few years of life. An inverse 
relation exists between the age of the patient and the tendency to close spontaneously. 
Of the patients seen at 1 month of age in 80% the VSD closes spontaneously, as do about 
60% of those seen at 3 months of age, 50% of those seen at 6 months, and about 25% 
of those seen at 12 months [2]. In contrast, in adults spontaneous VSD closure occurs in 
only 10% of the patients [11, 12].
Classic indications for ventricular septal defect closure have been substantial left-
right shunting with Qp: Qs >1.5, congestive heart failure, reversible pulmonary hyper-
tension, aortic valve regurgitation and endocarditis. Mostly this regards infants and 
children.
In young patients the indication for surgical closure of a VSD are most often volume-
overload related symptoms [7]. Surgical closure may decrease the risk of endocarditis, 
reduce pulmonary artery pressure, improve functional classiﬁcation and increase long-
term survival [13]. With advancing age symptoms are related to secondary eﬀects of a 
shunt, and persistent defects may predispose to endocarditis, aortic regurgitation and in 
selected cases to heart failure, arrhythmias and pulmonary hypertension [9].
Less clear remains the indication for congenital VSD in adults when the VSD is small, 
the right ventricular pressure is normal, the Qp/Qs is less than 1.5 and there is no aortic 
valve involvement. A VSD is not necessarily a benign anomaly and the course of patients 
depends on the size of the septal defect, the type of the defect and on possible con-
comitant anomalies [2].
Nowadays, VSDs are usually repaired through the right atrium and in selected cases 
through the great arteries. In the past, a right ventriculotomy and sometimes a left ven-
triculotomy was performed. When the exposure of the VSD through a right atriotomy 
is insuﬃcient the tricuspid valve can be detached to enhance exposure. Temporary 
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chordal detachment is an alternative for temporary tricuspid detachment in enhanc-
ing exposure of the VSD [14, 15]. All patients are operated upon with cardiopulmonary 
bypass (CPB) with moderate hypothermia and cardioplegic arrest. CPB is performed with 
arterial cannulation in the ascending aorta and bicaval cannulation. A (Gore-Tex®) patch 
is used to close the defect. Caution should be applied to the atrioventricular pathways 
of conduction in order to avoid complete heartblock. Permanent iatrogenic complete 
heart block develops in approximately 1% of the patients [16]. In perimembranous 
defects the bundle of His traverses subendocardially during its course inferoposteriorly 
to the margin of the defect. In some muscular defects, however this bundle may run 
anterosuperiorly to the defect [16].
A transcatheter approach for VSD closure is increasingly gaining interest [17]. 
Percutaneous VSD-closure has been described by Hijazi [18]. This group reported on 
transcatheter closure of a single muscular VSD using the Amplatzer® muscular VSD 
occluder and concluded that this is quite a successful procedure with good outcomes at 
6 months, however preferably used in muscular VSDs, because of the need for a suitable 
rim. The close proximity of the aortic valve makes this technique more complicated in 
VSD closure in perimembranous VSDs. For these patients, there is a potential risk of new 
or increased aortic or tricuspid regurgitation [19]. A prospective study of the same group 
reported on transcatheter closure of perimembranous VSD using the new Amplatzer 
Membranous VSD Occluder®. Serious adverse events were encountered in 8.6% of the 
patients, whereas the attempt to place the device was successful in 91%. Limitations 
of this study are that the patients were larger and older than those in whom surgical 
closure of a VSD is normally considered. The application of the Amplatzer Membranous 
VSD Occluder® in small infants may carry a higher risk and the results remain to be deter-
mined [20]. The most frequent complications after these procedures include rhythm and 
conduction disturbances [20]. So far, these results do not compare favourably with that 
of surgical closure [15, 17, 21].
POSTOPERATIVE OBSERVATIONS
Hospital mortality is low (≤1%) for repair of single large VSDs, which are repaired most-
ly in early infancy [2]. The risk is higher when the VSDs are multiple and when major 
associated cardiac anomalies coexist. The natural history in operated patients is mainly 
determined by the moment of operation and absence or presence of pulmonary hyper-
tension. Patients with normal pulmonary vascular resistance and without pulmonary 
vascular disease have a normal life expectancy, whereas those who underwent relatively 
late repair may have a degree of pulmonary vascular disease, which may aﬀect long-
term outcome [22].
16
C
ha
pt
er
 1
Conduction disturbances are frequently reported after repair of VSDs [16]. Right 
bundle branch block in repair of a perimembranous VSD through a right atriotomy was 
found in 34-44% of the patients, probably due to damage to the right bundle by sutures 
along the inferior border of perimembranous VSDs [23-25]. Serious ventricular arrhyth-
mias and sudden death late after repair of VSDs are rare [26]. The approximate incidence 
of postoperative complete heart block after surgical VSD closure is less than 1%, and is 
more prevalent in patients with multiple VSDs and inlet VSDs [27]. Postoperative left-
to-right shunts large enough to require reoperation are uncommon, 0.7% to 2% of the 
patients required reoperation for residual VSD [24].
Repair of VSD during the ﬁrst 1 or 2 years of life is curative for most patients, resulting 
in full functional activity and normal or near-normal life expectancy [2]. This is illustrated 
in personal health assessment and physical health, which are comparable to that of the 
normal population [23].
AIM OF THE STUDY
The aim of present thesis is to study aspects of surgery for a congenital VSD in early child-
hood and at adult age. Nowadays, echocardiography is the key diagnostic tool, which 
may accurately identify the location, size, and spatial relation of the VSD and has made 
cardiac catheterisation with regard to a VSD hardly ever indicated anymore. The possible 
role of three-dimensional echocardiography to further improve the diagnostic accuracy 
with regard to surgical closure of a VSD is studied in Chapter 2. Temporary detachment 
of the tricuspid valve is studied and discussed in Chapter 3 and 4, with special emphasis 
to tricuspid valve function and rhythm disturbances during follow-up.
Can techniques of cardio-pulmonary bypass be improved? We studied the eﬀects of 
hypothermia in two randomized groups in Chapter 5 and compared mild hypothermia 
(nasopharyngeal temperature ≥32°C during CPB) with moderate hypothermia (naso-
pharyngeal temperature ≥28°C during CPB).
An attempt to further increase the information on tricuspid valve function after VSD 
closure is made. In Chapter 6 the value of 3D-echocardiography and virtual reality in the 
postoperative assessment of surgical closure of a VSD is discussed. 
What happens to the residual shunts often seen early after surgery? In Chapter 7 
we studied a patient cohort with special emphasis for the residual shunt concerning the 
post-correction VSD.
The long-term follow-up of symptomatic patients operated at a young age is well 
studied [23, 28]. The follow-up of patients operated at adult age is less well known [7]. 
Quality of life of patients undergoing surgical closure during childhood is comparable 
to that of the normal population [23]. For those operated in adulthood this has not been 
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studied. Which were the indications for closing the VSDs, in which clinical condition was 
the patient, and how was the outcome clinically and with regard to quality of life? There-
fore we describe the follow-up, including quality of life of patients undergoing surgical 
closure of a VSD in adulthood. This study is described in Chapter 8.
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Three-Dimensional Echocardiography 
Enhances the Assessment of Ventricular 
Septal Defect
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J.R.T.C. Roelandt, and A.J.J.C. Bogers
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INTRODUCTION
Functional and morphologic assessment of ventricular septal defect (VSD) is routinely 
done with 2-dimensional (2D) and color Doppler echocardiography.[1–5] Usually, this 
provides adequate information to decide on surgical repair[6,7]. Nevertheless, the anat-
omy of the VSD is complex [8,9] and cannot be presented by actual imaging techniques 
in a single plane.[10] Furthermore, advances in cardiac surgical procedures increasingly 
demand support of highly accurate imaging techniques.
Three-dimensional (3D) echocardiography has been proposed as a new technique 
able to simulate the intraoperative visualization of cardiac structures and to improve 
the understanding of the anatomy of congenital heart disease.[11] An experimental 
study conducted on animals has shown that 3D echocardiography is feasible for VSD 
analysis.[12] However, until now, studies on patients for the assessment of VSD with 3D 
echocardiography are scanty and not validated by intraoperative ﬁndings.[13,14]
To deﬁne the clinical use of 3D echocardiography, we evaluated whether 3D echo-
cardiography can accurately identify and characterize the morphology of the VSD and 
assess its geometry and size in patients undergoing surgery. 
MATERIAL AND METHODS
Thirty patients (16 males and 14 females) with diagnosis on routine 2D echocardiog-
raphy of VSD were studied. The mean age was 6 ± 13 years (range 20 days to 61 years). 
Three patients were adults (age 18 to 61 years) and 27 were children (age 20 days to 6 
years). Body surface area was 0.72 ± 0.6 m2 (range 0.22 to 2.1). In 12 patients, the VSD 
was isolated. In 11 patients the VSD was associated with tetralogy of Fallot and in 3 with 
pulmonary atresia. In 1 patient the VSD was associated with double-outlet right ventricle 
and transposition of the great arteries, and in another patient with simple transposition 
of the great arteries. In the remaining 2 patients the VSD was a residual defect after cor-
rection of a complete atrioventricular VSD. 
Complete diagnostic transthoracic examination (2D echocardiography, pulsed 
Doppler wave, and color ﬂow mapping) for clinical assessment was performed using HP 
1500 (Hewlett-Packard, Andover, Massachusetts) echocardiographic equipment. Mul-
tiple cross sections imaging the VSD were taken from all windows, following a standard 
procedure.[6] The 3D echocardiographic acquisition was performed with a Toshiba SSH 
140-A (Toshiba, Otawara-Shi, Japan) or HP 1500, of which the video output was inter-
faced to the Echo scan 3.0 (TomTec, Munich, Germany) 3D reconstruction system. Twenty 
patients were studied by the transthoracic and 10 by the transesophageal approach. 
Transesophageal echocardiography was performed only in children using the Minimulti 
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probe (Oldelft, Delft, The Netherlands), which contains 48 transmitting elements and 
operates at a frequency of 5 MHz. Transthoracic echocardiography was performed with 
a 3.5-MHz probe. All children were studied under general anesthesia just before sur-
gery or cardiac catheterization. The 3 adult patients were studied in the Department of 
Echocardiography. Acquisition was performed with rotational scanning at 2° intervals 
for 90 steps, applying electrocardiography and respiratory gating.[15] During rotation, 
the VSD was kept in the center of the scan sector and care was taken that other cardiac 
structures like the tricuspid valve and the aortic valve were also encompassed for further 
spatial orientation and morphologic deﬁnition of the VSD. 
 The data were processed oﬀ-line and presented as a conical volumetric data set.[15] 
The 3D data sets were reconstructed and analyzed independently by 2 observers (AD, 
JMcG). From the volumetric data set, cut planes were selected using anyplane mode to 
visualize the ventricular septum on its left and right surface and in a longitudinal cross 
section. A gray level threshold was applied on the computer-generated 2D cut planes to 
separate the object from the background. Thus, 3D dynamic images with depth percep-
tion were created. A third observer (AC-D) analyzed the VSD on 2D echocardiography. 
Figure 1. Perimembranous ventricular septal defect (outlet) (arrow). A, view of the defect from the right aspect. The 
location of the defect in relation to the tricuspid valve and the outﬂow tract is shown. B, view of the defect from the 
left aspect. The location of the defect in relation to the aorta and the mitral valve is shown. Ao = aortic valve; LA = 
left atrium; LV = left ventricle; PPM = posterior papillary muscle; RA = right atrium; RV = right ventricle. 
Figure 2. Morphologic aspects of the ventricular septal defect (arrow) associated with pulmonary atresia, seen 
from the right (A) and from the left (B) surface. PV = pulmonary valve; other abbreviations as in Figure 1. 
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The location of the VSD (perimembranous, muscular, inlet, outlet), the relation to 
the tricuspid valve (tethering of the tricuspid valve leaﬂet, presence of abnormal chor-
dae), and to the aortic valve (degree of overriding) and its size were analyzed on both 
2D and 3D echocardiographic images. On the 3D reconstruction, the anteroposterior 
and superoinferior diameters were measured, whereas on 2D echocardiography only 
the diameter derived from a 4-chamber view (corresponding to the anteroposterior 
direction) was measured. The largest anteroposterior diameter of the VSD measured on 
3D images was compared with the largest anteroposterior diameter derived from 2D 
echocardiography. Morphologic accuracy was assessed postoperatively by presenting 
the dynamic 3D reconstructions of the VSD to the attending surgeon and correlating the 
data to the annotated intraoperative description. 
Measurements are expressed as mean ± SD. Intra-and interobserver variability and 
comparison between 3D and 2D data were analyzed by linear regression and Bland-Alt-
man analysis of agreement.[16] A p-value < 0.05 was considered signiﬁcant. 
RESULTS
The 3D data sets were adequate for reconstruction in 28 of 30 patients. In the other 2 
patients, a wrong gain setting and the presence of a large rotational artefact in the data-
set hampered the quality of the ﬁnal reconstruction. Seventy-nine 3D reconstructions, 
displaying the VSD from the right and the left aspect, from above the aortic valve and 
along its longitudinal cross section, were used for analysis. Twenty-four of 28 patients 
had a single perimembranous VSD with extension to the outlet septum, situated just 
below the aortic valve (Figures 1 and 2). In 1 of these patients there was an associated 
aneurysm of the sinus of Valsalva. Two patients had an inlet VSD, 1 a doubly commit-
ted VSD. In 1 patient multiple VSDs were visualized: 2 were muscular defects and 1 a 
perimembranous outlet defect. In 2 patients the tricuspid valve leaﬂet was tethering the 
defect and in 6 patients abnormal chordae from the tricuspid valve were attached to the 
ventricular septum and crossing the defect area (Figure 3). From 28 adequate horizontal 
3D cross sections above the aortic valve, overriding of approximately 50% was seen in 
12 patients and of >50% in 1 patient (Figure 4). 
There was complete agreement on morphology of the VSD between 3D and 2D 
echocardiography. However, 3D reconstructions were of additional value compared 
with 2D echocardiography in 6 of 28 patients (21%). Views of the right side of the VSD 
displayed the presence of abnormal chordae crossing the defect in 3 patients (Figure 
3), the amount of tricuspid valve surrounding the defect in 2 other patients, and the 
number of VSDs in another patient better than 2D echocardiography. Three-D echocar-
diography did not give better visualization of the doubly committed VSD and of the 
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VSD in relation to the Valsalva aneurysm. This was most probably due to the small size 
of the defects and the difﬁculty in obtaining an optimal 3D acquisition. Twenty-seven 
of 28 patients underwent surgical correction. The VSD was visualized through the right 
atrium and the tricuspid valve and closed in all cases with a Gore-Tex® patch (W.L. Gore & 
Associates, Inc., Flagstaﬀ, Arizona). The agreement on anatomy between 3D reconstruc-
tions and intraoperative ﬁndings was complete in all patients. 
Twenty-two facing views of the VSD were reconstructed and used for diameter mea-
surement. The anteroposterior diameter was 13 ± 8 mm (intraobserver agreement r = 0.9, 
p< 0.001; interobserver agreement r = 0.9, p <0.001), the superoinferior diameter was 18 
± 6 mm (intraobserver agreement r = 0.7, p <0.001; interobserver agreement r = 0.9, 
p <0.001). The largest 3D anteroposterior diameter was compared with the correspond-
ing 2D anteroposterior diameter (11.8 ± 4 mm). The correlation coefﬁcient between the 
measurements was r = 0.6 (p <0.05). 
Figure 3. Volume rendered image of the right ventricle (RV) displaying the right aspect of the ventricular septal 
defect (arrow) and abnormal chordae from the tricuspid valve crossing the defect. Abbreviations as in Figure 1. 
Figure 4. Horizontal cross section through the aortic valve from which it is possible to estimate the degree 
of overriding aorta (arrow). A, aortic valve overrides the ventricular septum (IVS) by <50%; B, in a patient with 
tetralogy of Fallot the overriding aorta is about 50%. MV = mitral valve; TV = tricuspid valve. 
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DISCUSSION
In this study we evaluated the accuracy and the potential of 3D echocardiography in 
the preoperative assessment of VSD. We showed that 3D echocardiography presents an 
accurate view of the anatomy of the VSD. The creation of cut planes, which display the 
VSD from its right aspect, reproduce the surgical viewpoint of a right ventriculotomy. 
From these images it is possible to deﬁne the morphologic nature of the margins of the 
defect, its shape, and the direction in which the defect extends into the ventricular sep-
tum. Other anatomic structures such as the tricuspid valve leaﬂet, the right ventricular 
outﬂow tract, and the aortic valve can be displayed in their realistic spatial distribution. 
More than 2D echocardiography, 3D views facilitate more complete visualization of 
chordae supporting the tricuspid valve leaﬂet crossing the defect. The tricuspid valve is 
sometimes thickened, immobile, and tethering the VSD, thereby limiting visualization of 
the VSD. Three-D echocardiography oﬀers the possibility of overcoming this limitation, 
exposing the defect completely by electronically deleting the leaﬂet or by creating a 
new cut plane in which the tricuspid leaﬂet is not present. 
Shunt size is a critical factor in management decisions. We are aware that shunt 
size does not necessarily correlate with the anatomic size of the defect. Nevertheless 
the dimensions of a defect play a role in the hemodynamic status of a patient with VSD. 
The most reliable way to size the defect is usually to measure its diameter either by 2D 
color ﬂow imaging or at cineangiography.[17–19] However, sizing can be difﬁcult when 
the VSD is associated with another lesion, such as coarctation or pulmonary stenosis. In 
this study, we demonstrate that 3D echocardiography can be considered a technique for 
accurate and reliable sizing. On 3D reconstructed images, it was possible to evaluate the 
exact shape and orientation of the VSD in 1 single plane and consequently to measure 
its 2 largest diameters in both directions. Sizing the VSD on 3D echocardiography has 
been shown to have good intra-and interobserver reproducibility.
In summary, this study shows that 3D echocardiography can be considered a valu-
able diagnostic tool, which may accurately identify the location, size, and spatial relation 
of a VSD.
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ABSTRACT.
In a consecutive series of 149 patients with congenital ventricular septal defect (VSD), 
temporary tricuspid valve detachment was applied in 39 (detached group) to facilitate 
the transatrial approach for closure of the defect. Baseline characteristics showed that, 
preoperatively, the detached group were younger (1.3 ± 2.3 vs. 3.5 ± 4.1 years, P = 0.002), 
shorter (0.67 ± 0.20 vs. 0.87 ± 0.34 m, P = 0.001), lighter (6.9 ± 5.4 vs. 13.5 ± 12.0 kg, P 
< 0.002), and had a higher mean right atrial pressure (6 ± 2 vs. 4 ± 3 mmHg, P < 0.003), 
mean enddiastolic right ventricular pressure (10 ± 3 vs. 8 ± 3 mmHg, P < 0.01) and mean 
pulmonary vascular resistance (267 ± 202 vs. 170 ± 131 dyn s cm-5, P < 0.02) on car-
diac catheterization. At surgery the aortic cross-clamp time was longer (48 ± 17 vs. 39 
± 15 min, P = 0.003). Seven patients died (2 detached, 5 not-detached), from causes not 
related to either tricuspid detachment or VSD closure.
Follow-up was complete with a mean duration of 2.0 years (range 0.1-5.5). All 142 
survivors were investigated by echocardiography, which showed normal tricuspid 
valve function in all but 29 patients who had trivial regurgitation (6 detached, 23 not-
detached). There was no tricuspid stenosis. In 30 patients (8 detached, 22 not-detached) 
a trivial residual VSD could be detected. One reoperation (not-detached) was performed 
12.5 months after the initial surgery for recurrent VSD.
Temporary tricuspid valve detachment for closure of a congenital VSD can be safely 
applied and does not impair growth of the tricuspid valve, regardless of age and preop-
erative clinical condition.
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INTRODUCTION
A congenital ventricular septal defect (VSD) can usually be closed via the transatrial 
approach. If surgical exposure of the VSD via this approach is not adequate, a ven-
triculotomy can be prevented by temporary tricuspid valve detachment, as originally 
described by Hudspeth et al. [4]. However, this technique has been accepted only hesi-
tantly because of concern about postoperative tricuspid valve competence [8]. More-
over, data on follow-up of the temporarily detached tricuspid valve are rare [1,4,8] and 
mostly based on only physical diagnosis and incomplete angiocardiography [1,4] or are 
investigated in selected series [8].
We describe our consecutive series of closure of congenital VSD including all patients 
with temporary detachment of the tricuspid valve, with a complete echocardiographic 
follow-up.
MATERIAL AND METHODS
A retrospective study was carried out of all 149 patients (90 male, 59 female) oper-
ated upon for a congenital VSD between 1985 and 1992. Excluded were patients with 
multiple VSDs, those with anomalies otherwise aﬀecting the ventricular septum and 
those over I6 years of age. Some of these patients have been included in earlier stud-
ies [2,3]. Nine patients had been operated upon previously, six for coarctation of the 
aorta (including three with ductal closure and one with ductal closure and banding of 
the pulmonary artery), two for ductal closure and one for pulmonary sling, treated with 
pulmonary artery re-implantation. The mean age for the whole group was 2.9 ± 3.8 years 
(range 2 weeks- 15.5 years). The mean weight was 11.7 ± 11.0 kg (range 2.3 -63.0) and 
mean weight percentile 21 ± 27 (range <3 - > 97). The mean height was 0.82 ± 0.32 m 
(range 0.93-1.77) and mean height percentile 29 ± 30 (range <3 -> 97). In the whole 
group 48 patients had recurrent respiratory tract infection, 79 patients were on diuretic 
medication and 55 were hospital-dependent. Thirty patients were in functional class I, 
8 in class II, 54 in class III, 57 in class IV and none in class V [6]. Electrocardiographic data 
were derived from standard 12-lead electrocardiograms. The criteria for left ventricular 
hypertrophy were met in 85 patients and for right ventricular hypertrophy also in 85. 
These numbers include 63 patients with biventricular hypertrophy. Preoperative chest 
X-ray showed cardiomegaly in 132 patients and increased pulmonary vascular markings 
in 136.
Preoperative echocardiography was carried out in 144 patients and included 2D 
and color-Doppler investigation. Our analysis was aimed at functional assessment of the 
tricuspid valve and the VSD. Tricuspid valve regurgitation was graded as none (n = 121), 
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trivial (n=23), moderate (n=0) or signiﬁcant (n=0), based on the area and the length of 
the color jet. Cardiac catheterization was performed in 94 patients preoperatively. The 
mean right atrial pressure was 5 ± 3 mmHg (range 0-10), the mean systolic right ventric-
ular pressure was 58 ± 22 mmHg (range 18-133) and mean enddiastolic right ventricular 
pressure 8 ± 3 mmHg (range 0-15). The mean Qp/Qs ratio was 2.8 ± 1.3 (range 0.8-7.0). 
The mean pulmonary vascular resistance was 187± 150 dyn ·s ·cm-5 (range 8-713) and 
mean systemic vascular resistance 1746 ± 610 dyn ·s ·cm-5 (range 618-4680). 
All patients were operated with cardiopulmonary bypass and either cardioplegic 
arrest (n= 140) or circulatory arrest (n=9, all not-detached, in 4 cases electively and in 5 
cases because of concomitant aortic surgery). Extracorporeal circulation (n=149) took 
75 ± 27 min (range 32- 169). The aortic cross-clamp time (n=140) was 41± 16 min (range 
18 - 111). In 85 patients one or more concomitant anomalies were managed during 
the operation for VSD. These anomalies are listed in Table 1. An exclusively transatrial 
approach to the VSD was used in 116 cases, including all 39 with tricuspid detachment. 
The transatrial approach was combined with other incisions in 31 cases, which included 
6 with right ventriculotomy (made for concomitant pathology in 1 case), 15 with pul-
monary arteriotomy (made for concomitant pathology in 7 cases), 3 with both incisions 
(all 3 made for concomitant pathology), 3 with pulmonary arteriotomy and aortotomy 
(made for concomitant pathology in 2) and 4 with aortotomy (made for concomitant 
pathology in 2). An exclusively transaortic approach was used in 1 case, while a right 
ventricular and transaortic approach was used in another. No left ventriculotomy was 
used in this series. 
The type of VSD was determined at surgery: 127 were perimembranous (including 
8 with malalignment), 4 inlet, 12 outlet (including 1 with malalignment) and 6 muscular. 
In 39 patients temporary tricuspid detachment was performed, because of incomplete 
Table 1. Concomitant anomalies in temporary tricuspid detachment in closure of VSD
Pulmonary vein stenosis  1
Unroofed coronary sinus  1
Central ASD/OFO 70
Muscular subpulmonary obstruction 10
Valvular pulmonary stenosis  6
Discrete subaortic stenosis  2
Aortic coarctation  5
Pulmonary coarctation  1
Patent arterial duct  6
Tracheal obstruction (pulmonary sling)  1
Banding pulmonary artery  1
ASD = atrial septal defect, OF0 = open foramen ovale, VSD = ventricular septal defect
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exposure of the VSD through the right atrium in 38 patients and through right ventricu-
lotomy in 1 case. Depending on the location of the VSD, the septal (n=6), the anterior 
(n=24), or both these leaﬂets (n=9) of the tricuspid valve were dissected from the annu-
lus. Closure of the VSD was performed either with a Dacron patch (n=29), a pericardial 
patch (n=1), primarily (n=23) or with a Gore-Tex patch (n=96). The suturing technique 
was essentially interrupted (n=25) or essentially running (n=124), with silk (n=2), Prolene 
(n=59) or Surgilene (n=75), while the suturing material was not established in 13 cases. 
After closure of the VSD, the tricuspid leaﬂets were reattached with running 7-0 or 6-0 
Prolene. 
Intraoperative post-correction epicardial echocardiography (Table 2) was carried 
out in 84 cases (31 detached, 53 not-detached) and included 2 D and color-Doppler 
studies as well as assessment of left-to-right shunting by echo-contrast injection into 
the left atrium [2, 3]. The tricuspid valve function was evaluated in the same way as pre-
operatively. Residual VSD was deﬁned by a modiﬁcation of criteria previously published 
Table 2. Intraoperative echocardiography (n = 84) in temporary tricuspid detachment in closure of VSD
Detached
(n=31)
Non-detached
(n=53)
P
Tricuspid regurgitation none 28 51 ns
trivial  3  2
moderate  0  0
signiﬁcant  0  0
Residual VSD none 26 48 ns
trivial  5  5
moderate  0  0
signiﬁcant  0  0
ns = not signiﬁcant,VSD = ventricular septal defect
Table 3. Follow-up echocardiography (n = 142) in temporary tricuspid detachment in closure of VSD
Detached
(n = 37)
Non-detached
(n= 105)
P
Tricuspid regurgitation none 31 82 ns
trivial  6 23
moderate  0  0
signiﬁcant  0  0
Tricuspid stenosis  0  0 ns
Residual VSD none 29 83 ns
trivial  8 22
moderate  0  0
signiﬁcant  0  0
ns = not signiﬁcant, VSD = ventricular septal defect
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[3]: no residual VSD was deﬁned as no or minimal contrast shunting with no detectable 
color jet, a trivial residual VSD as minimal contrast shunting with a minimal color jet, a 
moderate residual VSD as moderate contrast shunting with any color jet and a signiﬁ-
cant residual VSD as substantial contrast shunting with any color jet.
Follow-up was complete and ended at the last outpatient visit or at reoperation. Fol-
low-up echocardiography (n=142) was also aimed at evaluating tricuspid valve function 
and possible residual VSD (Table 3). The criteria for tricuspid valve regurgitation were 
the same as used preoperatively and intraoperatively. Special attention was paid to pos-
sible tricuspid valve stenosis. The criteria for residual VSD were the same as applied in 
the intraoperative echocardiography. Only 5 patients had cardiac catheterization during 
follow-up, for reasons not related to tricuspid valve function or possible VSD. 
The analysis of categorical variables, summarized in terms of relative frequencies, 
was performed using the chi-square test with the Yates correction or using Fisher’s exact 
test. Continuous variables, described as the mean±standard deviation, were analyzed 
using Student’s t-test. Probability values smaller than 0.05 were considered signiﬁcant.
RESULTS
Diﬀerences were found between the groups with and without tricuspid detachment. 
The group with tricuspid detachment was younger (1.3 ± 2.3 vs 3.5 ± 4.1 years, P= 0.002), 
lighter in weight (6.9 ± 5.4 vs 13.5 ± 12.0 kg, P < 0.002), lighter in weight percentile (12 
± 19 vs 24 ± 29, P = 0.01), shorter (0.67 ± 0.20 vs 0.87 ± 0.34, P= 0.001), but not in length 
percentile (22 ± 30 vs 31 ± 30). The patients in the detached group were more often on 
diuretic therapy (28/39 vs. 51/110, P=0.01), but no signiﬁcant diﬀerence could be found 
in functional class (class I 5/39 vs 25/110, class II 1/39 vs 7/110, class III 14/39 vs 40/110, 
class IV 19/39 vs 38/110). In the detached group the preoperative electrocardiogram 
showed right ventricular hypertrophy more often (28/39 vs 59/110, P=0.03). The preop-
erative chest X-ray showed cardiomegaly more often in the detached group (38/39 vs 
94/110, P= 0.01), but did not diﬀer in pulmonary vascular markings.
On preoperative echocardiogram (n=144) tricuspid valve regurgitation did not dif-
fer between the two groups (none 30/39 vs 91/105, trivial 9/39 vs 14/105). At preop-
erative cardiac catheterization (n=94) the detached group (n=18) showed higher mean 
pressures in the right atrium (6 ± 2 vs 4 ± 3 mmHg, P < 0.003), higher enddiastolic right 
ventricular pressure (10 ± 3 vs 8 ± 3 mmHg, P< 0.01) and higher pulmonary vascular 
resistance (268 ± 202 vs 170 ± 131 dyn ·s ·cm-5, P< 0.02). 
Although the duration of cardiopulmonary bypass did not diﬀer signiﬁcantly for the 
detached group (79 ± 23 vs 74 ± 28 min), the aortic cross-clamp time (n=140) was longer 
(48 ± 17 vs 39 ± 15 min, P < 0.004). The detached group did not diﬀer from the not-
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detached group in the kinds of VSD: perimembranous (37/39 vs 90/110), outlet (2/39 vs 
10/110), inlet (0/39 vs 4/110), muscular (0/39 vs 6/110). Malalignment also did not diﬀer 
between the groups (5/39 vs 4/110).
As shown in Table 2, intraoperative post-correction epicardial echocardiography 
(n=84) showed no diﬀerence in tricuspid valve incompetence between the detached 
and the non-detached groups. There was also no diﬀerence in residual VSD between the 
two groups. There were no cases of complete heart block.
Early mortality occurred in 7 patients (2 detached, 5 non-detached). None were relat-
ed to tricuspid detachment or VSD closure. The cause of death was pulmonary hyperten-
sion (n=2, both detached), sepsis (n=1), meningo-encephalitis (n=1). One patient died 1 
week postoperatively during an operation for infected trachea reconstruction.
Follow-up was complete with a mean duration of 2.0 years (range 0.1-5.5). The mean 
weight percentiles increased for the whole group to 40 ± 33, as did the mean height 
percentile: to 40 ± 33. The whole group showed a deﬁnite improvement in functional 
class (class I 122, class II 17, class III 1, class IV 2, class V none).
All 142 surviving patients underwent 2 D and color-Doppler echocardiography. As 
shown in Table 3, normal tricuspid valve function was found in all but 29 patients with 
trivial regurgitation (6 detached, 23 non-detached, not signiﬁcantly diﬀerent). Tricuspid 
stenosis was absent on continuous wave Doppler echocardiography. In 30 patients (8 
detached, 22 non-detached, not signiﬁcantly diﬀerent) a trivial residual VSD could be 
detected. One patient (non-detached) was re-operated for recurrent VSD 12.5 months 
after the initial surgery.
DISCUSSION
Temporary tricuspid detachment is an attractive surgical alternative for the repair of 
a congenital VSD in patients in whom transatrial exposure of the VSD is incomplete 
[1,4,7,8]. Nevertheless, temporary tricuspid detachment has not met with widespread 
acceptance because of concern about postoperative tricuspid valve function [8]. These 
reservations mostly concern regurgitation but, in the long-term, growth of the tricuspid 
annulus might also be impaired, possibly leading to tricuspid valve stenosis. Moreover, 
in recent textbooks the technique of temporary tricuspid detachment is only described 
for exceptional situations and is not further analyzed or commented on [5,7]. 
Because of the lack of comparable series, it is interesting to note how often tricus-
pid detachment was used. In our consecutive series of 149 patients with a VSD, a right 
atriotomy was undertaken in 147 patients. In 2 cases one or more other approaches 
were used and in 31 cases one or more additional approaches were used in closing the 
VSD (22%), of which 15 were performed for surgery of concomitant pathology. Overall, 
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in 10 cases (6%) a right ventriculotomy was made (in 6 just to approach the VSD, in 4 
to approach a muscular subpulmonary stenosis as well). These right ventriculotomies 
were performed in the early part of this study and would probably not have been made 
nowadays, because closure of a VSD as well as surgery for muscular subpulmonary 
obstruction can well be carried out without right ventriculotomy [7]. In 116 cases an 
exclusively right atrial approach was used (77%). In 39 of these cases temporary tricus-
pid detachment was applied (34% of those with an exclusively transatrial approach and 
26% of the whole series).
All temporary tricuspid valve detachments in our series were performed for peri-
membranous or outlet VSDs. Apparently this technique was not necessary in closing 
VSDs in the inlet or muscular parts of the ventricular septum.
Nevertheless, temporary tricuspid detachment has been described to facilitate clo-
sure of inlet VSDs [7,8]. The procedure was signiﬁcantly associated with patients that 
were younger, lighter in weight, shorter and more often on diuretic therapy. This was, 
however, not reﬂected in a worse functional class. The tricuspid detachment group 
showed more signs of right ventricular overload on electrocardiogram and cardiac cath-
eterization although these preoperative characteristics were not associated with diﬀer-
ences in outcome. Seven patients died in hospital for reasons not directly associated 
with VSD closure or tricuspid detachment and repair.
Intraoperative epicardial echocardiography was carried out in 84 cases and showed 
only a trivial residual VSD in 12% and only trivial tricuspid regurgitation in 6%. In the 
complete follow-up, echocardiography showed only a trivial residual VSD in 21% and 
trivial tricuspid regurgitation in 20%. Speculations can hardly be made about the diﬀer-
ences between intraoperative epicardial and follow-up transthoracic echocardiography, 
because the intraoperative series was not complete and contrast echocardiography 
could not be used in both investigations. Furthermore, these echocardiographic studies 
were carried out by diﬀerent investigators and under diﬀerent hemodynamic conditions. 
However, a selected series with incomplete echocardiographic follow-up also reported 
only trivial tricuspid regurgitation [8], although these authors found a 45% incidence of 
tricuspid valve regurgitation [8]. In our study, follow-up echocardiography did not show 
any signs of tricuspid valve stenosis. As the whole group showed above normal growth 
according to weight and height percentiles, we assume that tricuspid valve growth was 
not impaired by tricuspid detachment.
We conclude that, regardless of the age, size and preoperative clinical condition 
of the patients, and regardless of the right ventricular load, temporary detachment of 
the tricuspid valve in closure of a congenital VSD can be performed safely, without any 
negative eﬀect on growth or function of the valve at medium-term follow-up.
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With great interest we read the How to Do It report by Kapoor and colleagues describing 
temporary detachment of tricuspid chordal attachment to improve exposure in closure 
of ventricular septal defect in cases with obstructing chordae tendinae of the septal 
leaﬂet [1]. Although Kapoor and colleagues do not present any follow-up data, they put 
temporary chordal detachment forward as an alternative to temporary detachment of 
the anterior or septal tricuspid leaﬂet from the tricuspid annulus, as described by us and 
originally by Hudspeth and colleagues [2,3]. Apparently temporary chordal detachment 
is applicable, but the arguments being put forward are arguable. We fully agree that 
optimal exposure is the main goal of these techniques and that these techniques are 
only to be applied in a limited number of operations. Moreover, in our experience, it is 
not the inferior rim of the ventricular septal defect that poses a technical problem in 
situations with a limited exposure. 
Exposure through detached leaﬂet tissue depends on an adequate length of the 
detachment incision. The location and extent of the detachment incision may vary 
according to the location of the ventricular septal defect. If, in this regard, a retractor 
is still necessary instead of stay sutures, it is not to be used for traction as Kapoor and 
colleagues state, but just for holding. 
Any surgical technique should be applied in a technically adequate and accurate 
way in order to avoid unnecessary “awkward” [1] situations. In this regard, temporary tri-
cuspid detachment intrinsically involves a rim of about 1 mm at the base of the tricuspid 
annulus, onto which the ventricular septal defect patch as well as the detached tricuspid 
leaﬂet is sutured. 
Temporary chordal detachment to improve exposure in closure of ventricular septal 
defect may be useful in selected cases. Arguments in favor, however, should preferably 
come from obvious advantages or from careful follow-up. 
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ABSTRACT
Background. Moderate hypothermia of 28°C is widely accepted in cardiac surgery 
with cardiopulmonary bypass (CPB). Recently however, several studies suggested that 
normothermic or “tepid” bypass techniques might improve the clinical outcomes for 
patients undergoing cardiac operations.
Methods. To assess the eﬀect of bypass temperature management strategy in pediatric 
patients undergoing correction of ventricular septal defect, 26 patients with body weight 
under 10 kg were randomly assigned to two treatment groups: Group 1, mild hypo-
thermia, patients cooled to nasopharyngeal temperature of 32°C during the bypass; or 
Group 2, moderate hypothermia of 28°C. Clinical parameters were recorded and blood 
samples were obtained just before, during, and 24 hours after operation.
Results. All the population characteristics and intraoperative variables were similar in 
the two groups. Hematologic data after CPB and protamine administration revealed a 
signiﬁcantly (p<0.05) longer activated partial thromboplastin time in the 32°C group; 
however, the diﬀerence in blood loss did not reach signiﬁcance.
Conclusion. Our study shows that both perfusion temperatures equally well facilitated 
CPB for this type of intracardiac surgery
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INTRODUCTION.
Until recently, intracardiac repair in pediatric cardiac surgery was mostly performed with 
moderate (27 - 30°C) to profound (< 25°C) systemic hypothermia. The exceptions to this 
rule were short procedures for which only mild (30 - 32°C) hypothermia was used.
Systemic hypothermia reduces tissue metabolic rate and oxygen demand and is 
used to protect the myocardium and the brain against potential ischemic insult [1-3]. 
Furthermore, it enhances protection of the other organs. Systemic hypothermia allows 
us to lower the arterial blood ﬂow and promotes better conditions in the operation ﬁeld 
as well as less blood trauma occurrence. Hypothermia also causes marked changes in 
the peripheral circulation, hormonal body response and alterations in organ function. 
Generalized inﬂammatory response, involving the complement, coagulation, kallikrein 
and ﬁbrinolytic cascades, is often a dominant feature of hypothermic bypass [4-6]. 
Undoubtedly, hypothermia has its positive as well as negative aspects during cardio-
pulmonary bypass (CPB). Therefore, normothermic CPB with warm cardioplegia in adult 
cardiac surgery is becoming increasingly popular [7].
In pediatric heart surgery, technical developments and enhanced surgical skills also 
allow for reduction of depth of hypothermia in most procedures. Nevertheless, com-
paratively few publications have addressed the issues raised by maintenance of mild or 
moderate hypothermia during pediatric bypass.
The aim of this study was to compare clinical results between two groups of pediat-
ric patients, operated with short aorta occlusion times and mild or moderate hypother-
mic CPB.
MATERIAL AND METHODS
Patients
The study population comprised 26 consecutive pediatric patients who underwent 
closure of ventricular septal defect (VSD) with use of a Gore-Tex patch. Only children 
with body weight under 10 kg and without concomitant heart disease were included. 
Exclusion criteria were: respiratory insuﬃciency with need of respiratory support; kid-
ney failure; liver failure; and neurological impairment. Patients were equally random-
ized into two groups: Group 1, mild hypothermia (nasopharyngeal temperature ≥ 32°C 
during CPB); Group 2, moderate hypothermia (nasopharyngeal temp. ≥ 28°C during 
CPB). One surgeon performed all operations. The study was conducted according to the 
regulations of the hospital medical ethical committee. Informed parental consent was 
obtained for all patients.
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Anesthesia
Patients were premedicated with 0.3-mg/kg-midazolam suppositorium 1 hour before 
induction of anesthesia. Induction of anesthesia was done by inhalation (halothane or 
sevoﬂurane) or intravenously (midazolam, pavulon, fentanyl). Patients were intubated 
with a nasal - endotracheal tube and ventilated with a minute volume of 10 ml/kg/min. 
Heart rate, ECG, arterial and right atrial blood pressure, nasopharyngeal and rectal tem-
perature, were continuously measured. A bladder catheter was inserted to monitor urine 
production during and after the operation.
Cardiopulmonary bypass
All patients were operated upon with CPB and cardioplegic arrest. In all patients, the 
ascending aorta was cannulated with either an 8 or 10 Fr. standard straight-tip cannula, 
depending upon patient size. In all cases, venous return was provided by bicaval can-
nulation of the superior and inferior caval veins with angled metal tip 12 Fr. cannulae.
CPB circuit consisted of a membrane oxygenator with integrated venous-cardioto-
my reservoir, roller pump with silicone tubing and an arterial line ﬁlter. The circuit was 
primed with Ringer’s solution and whole blood to achieve an intraoperative hematocrit 
of 28% during the bypass period. During CPB, nonpulsatile pump ﬂow with rates of 1.8 
-2.4 l/min/m2 was maintained adequate to metabolic needs of the patient. In-line moni-
toring of arterial oxygen tension (PaO2)
 and venous oxygen saturation (SvO2) provided 
conditions for alpha-stat strategy during the whole period of bypass. 
Anticoagulation of the patient and the CPB circuit were achieved with initial patient 
heparin dose of 300 IU / kg body weight and prime heparin dose of 4.2 IU/ml. total 
prime volume. Assessment of anticoagulation during operation was done by measure-
ment of the kaolin activated clotting time (ACT). The ACT values were maintained ≥ 
480 sec by administration of additional heparin when necessary. After discontinuation 
of the CPB, heparin was neutralized by protamine chloride with a standard dose of 4 to 
5 mg/ kg body weight. Adequacy of protamine reversal was ascertained with the use 
of heparin-protamine titration. No aprotinin was administrated to patients in the study 
population.
Patient mean arterial blood pressure was maintained between 30 - 65 mmHg during 
the bypass. Continuous recording of the pump ﬂow, arterial blood temperature, along 
with patient nasopharyngeal and rectal temperatures, oxygen and airﬂow, PaO2, SvO2, 
arterial line pressure, as well as patient pressures, was provided by “Odis”, a perfusion 
registration system [8, 9].
Myocardial preservation was achieved by antegrade administration of cold (4°C) 
St.Thomas Hospital cardioplegic solution delivered by gravity at the dose of 10 - 15 ml/
kg of body weight after application of the aortic cross-clamp. No topical cooling was 
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used. All patients were weaned from bypass with infusion of dopamine 2 µg / kg min 
and nitroglycerin 1 µg / kg /min.
Measurements and calculations
In both groups arterial and venous blood gas samples were obtained before bypass, 
during CPB after 5 min, 20 min, and at the end (± 50 min). The last sample was obtained 
after administration of protamine chloride. During CPB, oxygen consumption index 
(Vo2 I) and systemic vascular resistance (SVR) were calculated as follows:
SVR =
mean arterial pressure - central venous pressure
x 80 dynes.sec.cm-5
cardiac output
Vo2 I = cardiac index x [(arterial saturation - venous. saturation) x Hgb x 2.32] ml/min m
2
Coagulation factors were platelet count, ﬁbrinogen, activated partial thromboplastin 
time (APTT), and thrombin time (TT), which were measured before the bypass, after 
protamine chloride administration, and 24 hours after the operation.
Other measured and recorded variables include: occurrence of electrical activity 
(ECG) during the aortic cross clamping, spontaneous cardiac conversion after releasing 
of the clamp, and existence of any sort of rhythm disturbances. Also, the amount of 
administrated blood products, diuresis, blood loss, length of the respiratory support and 
stay in the intensive care unit (ICU) were recorded.
Intraoperative postcorrection epicardial echocardiography [10] was carried out with 
color-Doppler studies to assess left-to-right shunting by echo-contrast injection into the 
left atrium. After 24 hours postoperative, left ventricular function was determined by 
echocardiography and follow-up was completed at the discharge visit. 
Data analysis
All values are presented as mean ± standard deviation (SD) of the mean. Two-way analy-
sis of variance (ANOVA) for repeated measurements was used for comparison between 
the groups at speciﬁc points in time. p-Values were obtained for the over-all group 
eﬀect. Other data were compared by paired t-test between the two groups. p-Values ≤ 
0.05 were considered statistically signiﬁcant.
RESULTS
There were no signiﬁcant diﬀerences in the baseline data between the two groups 
(Table 1). Mean nasopharyngeal (N) and rectal (R) temperatures after 5 min on CPB were 
not signiﬁcantly diﬀerent (Group 1; N: 32.5 ± 0.0 R: 33.0 ± 0.1 vs. Group 2; N: 31.9 ± 0.0 R: 
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33.2 ± 0.1°C, NS). After 20 min on bypass, a signiﬁcance occurred (Group 1; N: 31.6 ± 0.0 
R: 32.3 ± 0.1 vs. Group 2; N: 29.2 ± 0.0 R: 30.9 ± 0.0°C with p = 0.008 and p = 0.01, respec-
tively). After 50 min on CPB and rewarming in progress, rectal temperature in Group 2 
was still signiﬁcantly lower (Group 1 R: 34.0 ± 0.1 vs. Group 2 R: 33.2 ± 0.0°C, p = 0.02), 
but nasopharyngeal temperatures were similar in the groups (Group 1; N: 35.8 ± 0.1 vs. 
Group 2; N: 35.3 ± 0.0°C, NS, Figure 1).
Hemodynamic parameters measured and calculated during CPB revealed no signiﬁ-
cant diﬀerences between recorded mean arterial pressure (Figure 2); on the other hand, 
Table 1. Characteristics and perfusion data of the study population.
Group 1 (32°C) Group 2 (28°C) p- value
Age (mo) 3.5 ± 1.6 5.0 ± 3.2 NS
Weight (g) 4250 ± 817 4958 ± 1245 NS
Height (cm) 56.8 ± 15.8 60.0 ± 4.5 NS
BSA (m2) 0.27 ± 0.03 0.30 ± 0.05 NS
Calc. Pump ﬂow (ml/min) 641 ± 83 713 ± 116 NS
Mean pump ﬂow (ml/min) 592 ± 12 597 ± 129 NS
CPB time (min) 54.5 ± 2.0 56.1 ± 16.0 NS
Crossclamp time (min) 31.5 ± 2.0 31.4 ± 15.0 NS
Cardioplegic solution (ml) 65 ± 30 65 ± 18 NS
All values reported as mean ± SD; NS, not signiﬁcant
CPB, cardiopulmonary bypass.
Calculated pump ﬂow = BSA (dm2) x 24 (ml/min/dm2)
Mean pump ﬂow = mean ﬂow during CPB
1WFig 1: Changes of  temperature during 
CPB.
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Figure 1. Changes of temperature during CPB.
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the overall cardiac index was signiﬁcantly higher in mild hypothermia group (Group 1; 
2.43 ± 0.2 vs. Group 2; 2.16 ± 0.2, p = 0.02, Figure 3).
During CPB, the moderate hypothermic group had signiﬁcantly higher over-all sys-
temic vascular resistance (Group 1; 1164 ± 389 vs. Group 2; 1703 ± 420 dynes.sec.cm-5, 
p = 0.04, Figure 4). Oxygen consumption was not signiﬁcantly diﬀerent in both groups 
at the time of measurements (Figure 5).
Venous oxygen saturation remained relatively steady in each group during the CPB 
period, and there was a signiﬁcant diﬀerence between the groups only at the 5-min 
bypass time (Group 1; 75% vs. Group 2; 66%, p = 0.01, Figure 6).
Atrial electrical activity (P wave) during aortic cross clamping was observed in four 
patients in Group 1 and in one in Group 2 (p= 0.04). No action was taken in any of these 
situations. All patients in both groups converted spontaneously to sinus rhythm after 
aorta declamping. AV block was temporarily observed in two patients in Group 1. The 
external pacing was applied before sinus rhythm returned.
Fig 2: Mean arterial pressure during 
CPB. 
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Fig 3: C.I. during CPB.
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Initial dose of heparin used before the start of CPB was not signiﬁcantly diﬀerent 
between both groups (Group 1; 1222 ± 290 vs. Group 2; 1500 ± 409 IU, NS). During CPB, 
two patients from Group 1 and one from Group 2 required additional heparin to sus-
tain ACT ≥ 480 sec. Standard protamine dose given in compliance with protocol was 
not signiﬁcantly diﬀerent. In each group, four patients required additional protamine 
(Group 1; 2.2 ± 3.4 mg. vs. Group 2; 2.4 ± 3.5 mg., NS). Preoperative measurement of 
                 
Fig 4: SVR during CPB.
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Fig 5: Oxygen consumption during 
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coagulation factors as well as baseline ACT in both groups were not signiﬁcantly diﬀer-
ent. After administration of protamine, the ACT values were still higher if compared with 
baseline values but did not show any signiﬁcant diﬀerence between groups; whereas, 
APTT values (Group 1; 55 ± 18 vs. Group 2; 41 ± 3 s, p = 0.045) were signiﬁcantly higher 
in mild hypothermia group (Table 2). There was no diﬀerence in diuresis, blood loss and 
the amount of blood products used during the period of 24 hours post CPB (Table 3).
                                                                                                               
Fig 6: SvO2 during CPB.
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Table 2. ACT values and plasma coagulation factors pre- and post- CPB.
Group 1 (32°C) Group 2 (28°C) p- value
Pre CPB
ACT (sec) 127 ± 16 132 ± 9 NS
APTT (sec) 48 ± 11 51 ± 17 NS
APTT ratio 1.6 ± 0.4 1.7 ± 0.6 NS
TT (sec) 19 ± 7 16 ± 2 NS
Fibrinogen (mg/dl) 220 ± 70 220 ± 50 NS
Platelets (x1000/mm3) 287 ± 55 315 ± 78 NS
Post CPB 
ACT (sec) 144 ± 35 141 ± 23 NS
APTT (sec) 55 ± 18 41 ± 3 0,045
APTT ratio 1.5 ± 0.1 1.4 ± 0.1 NS
TT (sec) 15 ± 2 15.9 ± 3 NS
Fibrinogen (mg/dl) 160 ± 30 180 ± 40 NS
Platelets (x1000/mm3) 177 ± 61 183 ± 50 NS
All values reported as mean ± SD; NS, not signiﬁcant
ACT, activated clotting time; APTT, activated partial thromboplastin time
APTT ratio = patient’s APTT/ normal population APTT
TT, thrombin time
54
C
ha
pt
er
 5
Also, the mean duration of postoperative ventilatory support, as well as the highest 
percentage of oxygen used in inspiratory fraction (FiO2 %), and applied positive end 
expiratory pressure (PEEP) were similar (Table 4). 
 The mean duration of stay at the ICU by patients in both groups was not signiﬁ-
cantly diﬀerent.
Intraoperative epicardial echocardiography revealed a residual VSD with insigniﬁ-
cant leakage of contrast in two patients from Group 1 and three patients from Group 2. 
At discharge, two patients in Group 1 displayed a hemodynamically insigniﬁcant residual 
VSD as well as one patient in Group 2. No residual VSDs were observed on subsequent 
follow-up visits. Intraoperative postcorrection epicardial echocardiography assessed left 
ventricular function in all patients as normal. Echocardiographic examination after 24 
hours estimated left ventricular function as “diminished” in three patients in Group 1 
and one patient in Group 2; nevertheless, at discharge, all patients regained normal left 
ventricular function.
DISCUSSION
Use of moderate (28°C) systemic hypothermia improves operating conditions and allows 
lower arterial ﬂow rates. This, in turn, reduces collateral coronary circulation and con-
tributes to myocardial protection as well as protection of other vital organs. Therefore, 
moderate hypothermia is widely carried out, although the eﬀects of skin and, perhaps, 
muscle ischemia related to this temperature and the increased sympathetic eﬀects may 
Table 3. Urine production and blood balance in 24 hours after CPB 
Group 1 (32°C) Group 2 (28°C) p– value
Urine excretion (ml) 345 ± 44 350 ± 111 NS
Blood loss (ml) 109 ± 106 95 ± 24 NS
Use of homologous blood (ml) 175 ± 39 145 ± 53 NS
Use of FFP (ml) 63 ± 117 106 ± 90 NS
All values reported as mean ± SD; NS, not signiﬁcant
FFP, fresh frozen plasma.
Table 4. Postoperative use of the respiratory support.
Group 1 (32°C) Group 2 (28°C) p- value
Respiratory supp. (h) 22.8 ± 18 16.5 ± 19 NS
Highest FiO2 (%) 48.8 ± 11 46.0 ± 10 NS
PEEP (cm H2O) 3.5 ± 0.8 3.7 ± 1.0 NS
All values reported as mean ± SD; NS, not signiﬁcant
FiO2, inspiratory fraction of oxygen
PEEP, positive end expiratory pressure
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balance out any potential advantages [11]. Another eﬀect of hypothermia is that blood 
viscosity increases so that use of appropriate hemodilution is required to reduce the 
systemic vascular resistance during CPB [12]. Hypothermia together with hemodilu-
tion disturbs coagulation and ﬁbrinolitic cascades; this is assumed to be responsible for 
enhanced blood loss during and after operation [13]. In certain operations, the selection 
of CPB temperature is dependent on the complexity of the operation; for example, deep 
hypothermia during circulatory arrest. Therefore, questions may be raised as to what 
the best temperature is in the case of short (under 1h of CPB time) surgical procedures 
for small pediatric patients with body weight less than 10 kg. [14]. According to the 
surgeon’s opinion, use of moderate (28°C) or mild (32°C) hypothermia during correc-
tion of the ventricular septal defect had no inﬂuence on the technical complexity of the 
operation. 
The hemodynamic data obtained from both groups showed no diﬀerences in 
adequacy of the CPB. Mean arterial pressure and venous oxygen saturation were kept 
constant during the bypass without any diﬃculty, although patients from Group 1 (32°C) 
required signiﬁcantly higher CI to achieve this. On the other hand Group 2 (28°C) had 
signiﬁcantly higher over-all systemic vascular resistance during the CPB, which might 
be caused by moderate hypothermia. Oxygen consumption in the two groups was not 
signiﬁcantly diﬀerent, which can be explained by the negligible diﬀerences of patient’s 
temperatures during long times on CPB.
Myocardial protection in both groups was the same, and there was spontaneous 
return of sinus rhythm in all the cases. In Group 1 (32°C) atrioventricular block occurred 
twice, which had to be resolved by temporary use of a pacemaker. Those adverse events 
could be related to less adequate myocardial protection, but also could be associated 
with the surgical procedure itself. There were no clinical consequences of these events, 
and the echocardiographic control of the left ventricular function showed no diﬀerence 
between the patients from both groups. Kidney function assessed by urinary output and 
lung function assessed by duration of ventilatory support did not diﬀer in both groups.
The amount of heparin and protamine used showed no diﬀerence in the two groups. 
Postoperative, after administration of protamine, both groups still had prolonged ACT 
values and signiﬁcantly lower plasma ﬁbrinogen concentration when compared to the 
“baseline” values, but Group 1 (32°C) also had signiﬁcantly longer APTT in comparison to 
Group 2 (28°C). Mean blood loss was least in the moderate hypothermia group, but the 
diﬀerence did not reach signiﬁcance. Hematologic data suggested increased ﬁbrinolitic 
potential in the mild hypothermia group [15].
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CONCLUSIONS
Our study documented no diﬀerence in organ preservation depending on type of hypo-
thermia, mild or moderate, used during the reconstruction of VSD in pediatric patients. 
The chosen temperatures did not impair adequacy of CPB. There was no diﬀerence in 
technical complexity of the operation. Moreover, the clinical outcome of the patients 
did not depend on the type of hypothermia. There were suggestions of more activation 
of ﬁbrinolitic potential in the 32°C group.
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ABSTRACT
Background: This study was done to investigate the potential additional role of virtual 
reality, using three-dimensional (3D) echocardiographic holograms, in the postoperative 
assessment of tricuspid valve function after surgical closure of ventricular septal defect 
(VSD).
Methods: 12 data sets from intraoperative epicardial echocardiographic studies in 5 
operations (patient age at operation 3 weeks to 4 years and bodyweight at operation 3.8 
to 17.2 kg) after surgical closure of VSD were included in the study. The data sets were 
analysed as two-dimensional (2D) images on the screen of the ultrasound system as 
well as holograms in an I-space virtual reality (VR) system. The 2D images were assessed 
for tricuspid valve function. In the I-Space, a 6 degrees-of-freedom controller was used 
to create the necessary projectory positions and cutting planes in the hologram. The 
holograms were used for additional assessment of tricuspid valve leaﬂet mobility.
Results: All data sets could be used for 2D as well as holographic analysis. In all data sets 
the area of interest could be identiﬁed. The 2D analysis showed no tricuspid valve steno-
sis or regurgitation. Leaﬂet mobility was considered normal. In the virtual reality of the 
I-Space, all data sets allowed to assess the tricuspid leaﬂet level in a single holographic 
representation. In 3 holograms the septal leaﬂet showed restricted mobility that was 
not appreciated in the 2D echocardiogram. In 4 data sets the posterior leaﬂet and the 
tricuspid papillary apparatus were not completely included.
Conclusion: This report shows that dynamic holographic imaging of intraoperative 
postoperative echocardiographic data regarding tricuspid valve function after VSD clo-
sure is feasible. Holographic analysis allows for additional tricuspid valve leaﬂet mobility 
analysis. The large size of the probe, in relation to small size of the patient, may preclude 
a complete data set. At the moment the requirement of an I-Space VR system limits the 
applicability of virtual reality 3D echocardiography in clinical practice.
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INTRODUCTION
As recently described the mental conceptualization and evaluation of the intracardiac 
anatomy from multiple two-dimensional (2D) echocardiographic images, is compli-
cated by cardiac dynamics [1-4]. Three-dimensional (3D) echocardiography facilitates 
simpliﬁcation of this process by oﬀering a direct representation of the cardiac anatomy 
throughout the cardiac cycle [4]. To appreciate the full 3D potential of these datasets, 
virtual reality technology can be applied and used for further interpretation of the data 
of cardiac echocardiography [4-9]. In this regard we applied holographic analysis of 
intraoperative epicardial echocardiography in order to further contribute to the discus-
sion of tricuspid valve function after surgical closure of ventricular septal defect (VSD) 
[10-13].
MATERIAL AND METHODS
Patients and data sets.
12 data sets from intraoperative epicardial echocardiographic studies in 5 operations 
(patient age at operation 3, 6, 7 weeks, 9 months and 4 years and bodyweight at opera-
tion 3.8, 3.9, 4.5, 5.2 and 17.2 kg) were included in the study. Epicardial echo was indi-
cated in these patients on clinical grounds to obtain additional 2D imaging on top of the 
pre-operative echo assessment. During the epicardial echocardiography, the 3D data 
sets were obtained as well.
All operations concerned closure of VSD, in 1/5 as isolated defect, in 3/5 in the set-
ting of correction of tetralogy of Fallot, in 1/5 in combination with a double-chambered 
right ventricle. In none of the operations the technique of temporary tricuspid detach-
ment was used. In 3 of the operations sutures of the VSD patch were anchored in the 
base of the tricuspid valve annulus. The postcorrection epicardial echocardiography was 
performed as previously described [14].
Three-dimensional echocardiographic data acquisition.
In the setting described previously [4] the data sets were acquired with the iE33 ultra-
sound system equipped with 3D data acquisition software (Philips Medical Systems, 
Andover, MA, USA), using an X3-1 broadband matrix array transducer (Philips Medical 
Systems, Andover, MA, USA) that was used epicardially after the surgical correction. 
Epicardial echocardiography took 4- 5 minutes in each patient and included 2D echo 
analysis and acquisition of the 3D data sets. The echocardiographic study, including real-
time 3D acquisition, was done with ECG gating.
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Data processing consisted of the creation of a Cartesian volume in DICOM 3.0 for-
mat by interpolating the original data using the export module of the Q-lab ultrasound 
data analysis application (Philips Medical Systems, Andover, MA, USA), using the highest 
quality settings.
The 3D image data were transferred to an SGI Prism computer (Silicon Graphics, 
Mountain View, CA, USA) driving the I-space virtual reality (VR) system. A simple format 
conversion was required to be able to load the data in the I-Space software. In total the 
processing and the conversion only took 1-2 minutes per dataset. Holographic analysis 
took 15-18 minutes for a single data set
Visualisation in the virtual reality environment.
The BARCO I-space (Barco, Kortrijk, Belgium) installed at the Erasmus MC (Erasmus MC, 
Rotterdam, The Netherlands) is a so-called four-walled CAVE™-like VR system[15]. In the 
I-Space researchers are surrounded by computer-generated stereo images, which are 
projected by 4 high quality DLP-projectors on three walls and the ﬂoor of the projection 
room. The CAVORE volume rendering application [16] is used to investigate 3D ultra-
sound images during the cardiac cycle [10]. In the I-Space, this results in an animated 
hologram of the dataset being visualised, ﬂoating in space in front of the viewers. The 
viewers wear a pair of lightweight glasses with polarising lenses that allows seeing the 
hologram with depth. A wireless 6 degrees-of-freedom (DOF) controller which emits a 
virtual pointer is used for manipulation of and interaction with this hologram. A cutting 
plane attached to the pointer allows assessment of the interior of the heart. A transfer 
function widget operated by the pointer controls the contrast and transparency of the 
rendered image.
The cardiothoracic surgeon performed the virtual reality 3D echo analysis.
Figure 1. A 3D hologram of a right atrial view of the tricuspid valve after VSD closure.
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RESULTS
In the 2D representation of the datasets the area of interest could adequately be visu-
alized in all of the 12 data sets. The data sets were used intraoperatively for clinical 
assessment of the result of the operation. In none of the data sets 2D analysis showed 
tricuspid stenosis or regurgitation. Mobility of the anterior and septal tricuspid valve 
leaﬂets was considered to be normal in all data sets. In 4 data sets, the posterior leaﬂet 
was not included, because of the limitations of epicardial access of a large probe in a 
small patient. In the other 8 data sets no abnormalities of posterior leaﬂet motion were 
noted.
All the 3D datasets could be adequately analyzed in the I-Space. Virtual reality of the 
datasets allowed a complete assessment of the area of interest and easy investigation 
of the area of the reconstruction. The holograms of the area of closure of the VSD were 
adequately visualised from the right side of the ventricular septum.
Assessment of the tricuspid valve leaﬂet motion could well be accomplished from 
a right atrial view. In 3 data sets (in 3 diﬀerent patients) a restriction of the mobility of 
the septal leaﬂet was noted, that was not appreciated in the 2D analyses. In all these 3 
patients the VSD patch was anchored in the base of the septal leaﬂet of the tricuspid 
valve. No abnormalities in anterior leaﬂet motion were noted. In the limited nearﬁeld 
of the epicardial echocardiography only 8 posterior leaﬂets could be assessed, their 
mobility was considered normal. The holograms conﬁrmed that the papillary apparatus 
in these 4 data sets was incompletely acquired.
DISCUSSION
A virtual reality approach is presented to analyse the results of surgery for congenital 
VSD. The 3D echocardiographic data sets acquired epicardially and generated by a com-
mercially available echo system were used to construct a dynamic hologram inside an 
I-Space. All the datasets could be adequately analyzed in the I-Space, in which a single 
3D dataset is suﬃcient to create every view of interest.
Currently, large-scale VR facilities like the I-Space are only available in a limited 
number of research centres throughout the world. Desktop applications are being 
developed, for instance the Personal Space Station PSSTM (Personal Space Technologies, 
Amsterdam, The Netherlands). Therefore, the representation and analysis of diagnostic 
3D echocardiography by virtual reality has only been described very recently [4]. As 
a new application, this experience is extended to postoperative control of the results 
of surgery for congenital VSD, in datasets derived epicardially. This is a relevant topic 
because in closure of a VSD, the sutures of the patch are often anchored in the base of 
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the septal and anterior tricuspid valve leaﬂet and sometimes the tricuspid valve may be 
temporarily detached in the area of the septal and anterior leaﬂets in order to optimise 
the surgical approach [10-12]. Until now, tricuspid valve function was shown not to be 
aﬀected by these techniques [10,11]. Recently, temporary tricuspid detachment was 
even advocated to avoid early postoperative tricuspid valve function due to inadvertent 
traction [12]. As a consequence tricuspid valve function and growth are matters of inter-
est in this regard.
However, because the area of interest is in the nearﬁeld of the echoprobe, a com-
plete data set may be precluded, especially because of the large size of the probe that 
was available at the time of the study in relation to the small size of the patients and the 
limited exposure of the heart in them. Although no tricuspid valve stenosis or regurgita-
tion was found in our series by 2D analysis of the data sets, in 3 of them a restricted 
mobility of the septal leaﬂet was found by holographic analysis. This suggests that holo-
graphic analysis may provide additional data beyond conventional analysis. In general, 
diﬀerences in interpretation between 2D and 3D echo can well be explained [17]. In 2D 
echocardiography, tricuspid valve analysis only allows analysis of two leaﬂets per image 
plane. Usually these are the anterior and septal leaﬂets, or the anterior and posterior 
leaﬂets. Hardly ever the posterior and septal leaﬂets can be visualized in one image 
plane and never all three leaﬂets. In contrast, 3D echocardiography allows all three leaf-
lets to be seen in one view.
The virtual reality analysis can be done by the anatomy-expert, for instance the car-
diothoracic surgeon performing the operation, and depends to a lesser extent on the 
echocardiography-expert, for instance the cardiologist making the diagnosis.
Virtual reality in this regard provides an additional resource for postoperative qual-
ity control as well as for education with regard to the intracardiac repair of congenital 
VSD.
With the I-Space technology the complex postoperative cardiac anatomy of the 
closed congenital VSD, in relation to tricuspid valve function, can be appropriately visu-
alised in virtual reality. Unfortunately, at present the colour-Doppler data cannot yet be 
transferred to the I-Space, as the data is only available in a proprietary format.
For the clinical practice, virtual reality 3D echocardiography should be implemented 
on smaller systems, like desktop displays or single screen projection systems, to allow 
bedside use or application in the operating theatre or conference room.
In conclusion, epicardially derived data sets may be incomplete for nearﬁeld struc-
tures, especially when probe size mismatches with patient size. Still, the resulting 3D 
data sets nicely provide holographic data, which may provide additional information on 
tricuspid valve function after VSD closure.
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ABSTRACT
Background: The purpose of this retrospective study was to assess long-term outcome 
of children after surgical closure of a ventricular septal defect (VSD).
Methods: Between January 1992 and December 2001 a consecutive series of 188 
patients (100 females) were operated for closure of a VSD. Temporary tricuspid valve 
detachment (TVD) was applied in 46 patients (24%) to enhance exposure of the defect 
using transatrial approach. Pre-operative baseline characteristics showed that the 
detached group was younger (0.79 ± 1.8 vs 2.1 ± 3.5 years, p = 0.002) and had a lower 
weight (6.5 ± 6.4 vs 10.0 ± 11.0 kg, p = 0.009).
Results: There was no diﬀerence in cross-clamp time (temporary TVD 36.2 ± 11.3 vs non-
temporary TVD 33.6 ± 13.1 min, p = 0.228). Postoperative echocardiography showed 
that 67 patients (36%) had trivial/minimal regurgitation, 10 patients (22%) from the 
temporary TVD group vs 57 patients (40%) from the non-detached group (p = 0.02). 
There was no tricuspid stenosis. Hospital mortality comprised two patients (1%). One 
patient died due to a pulmonary hypertensive crisis and one in relation to an acute 
patch dehiscence for which an emergency reoperation was necessary. At ﬁrst postop-
erative echocardiography no shunting was detected in 113 patients, trivial shunting in 
73 and signiﬁcant shunting in none. Multivariate logistic regression analysis revealed 
that weight at operation was a predictive factor for the occurrence of residual shunting 
(OR 0.95, C.I. 0.91 – 0.99). One patient with conduction disturbances needed a perma-
nent DDD-pacemaker. Three patients were lost to follow-up. Mean follow-up time was 
2.6 years (range 0.1 -9.4). During follow-up no reoperations were necessary for closing 
a residual VSD. One patient died 7 months postoperative due to a bronchopneumonia. 
During follow-up in 37 (51%) of the 73 patients the trivial shunting disappeared sponta-
neously at a median time of 3.9 years. According to actuarial analysis all trivial shunting 
had disappeared at 8.4 years.
Conclusion: Trivial residual shunting disappeared spontaneously at a median follow-up 
time of 3.9 years. During follow-up no patient needed to be reoperated for residual VSD. 
TVD proved to be a safe method to enhance the exposure of a VSD.
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INTRODUCTION
The most frequent congenital cardiac anomaly is a ventricular septal defect (VSD) [1,2]. 
Many VSDs are small, asymptomatic and are assumed to close spontaneously [3]. In the 
VSDs that need closure, surgical treatment is aimed at prevention of pulmonary hyper-
tension, endocarditis or in some instances of progressive aortic valve regurgitation[4].
After surgical closure of a VSD trivial residual shunting is nowadays easily detected 
with modern sensitive echocardiographic techniques. However, the natural history of 
these small shunts is yet unknown especially with regard to temporary tricuspid valve 
detachment (TVD) [5]. In closing a VSD temporary TVD may provide better exposure of 
the defect in the usual transatrial approach [6-8]. Details of follow-up after surgical VSD-
closure using TVD are scarce with regard to tricuspid valve function and residual shunt-
ing. In this regard we report our analysis of patients who underwent surgical closure of 
a VSD under 17 years of age, between January 1992 and December 2001 with special 
emphasis on temporary TVD and spontaneous closure of residual trivial shunting.
MATERIAL AND METHODS
Between January 1992 and December 2001, 188 consecutive patients younger than 
17 years of age were operated upon for closure of a congenital VSD. The study group 
consisted of 100 female (53%) and 88 male (47%) patients. Although the mean age at 
operation was 1.8 years (range 2.5 weeks – 14.8 years) the median age was only 0.4 years. 
None of them had previously been operated upon. The Wolﬀ Parkinson White syndrome 
in 2 patients was medically controlled. One hundred and thirty-nine patients (75%) 
had one or more concomitant cardiac defects that were surgically corrected during the 
same operation. Patients’ characteristics are described in Table 1. Exercise intolerance 
was regarded present in the younger children when feeding times were reported to 
be prolonged and in the older children when ability to exercise was less compared to 
siblings. All patients were operated upon with cardiopulmonary bypass (mean duration 
of 64 ± 25 min, range 31 – 311 min). Mean cross-clamp time was 34 ± 13 min (range 
14 – 74 minutes). In all patients the VSD was approached through a right atriotomy. To 
enhance the exposure, the tricuspid valve was detached in 46 cases (24%): the anterior 
leaﬂet in 22 patients (48%), the septal in 10 (22%) and both leaﬂets in 14 (30%). TVD was 
selectively applied in cases with multiple chordal attachment to the rim of the VSD. The 
technique was exactly as described in our previous paper [6]. Essentially, the incision 
for detachment is made in the leaﬂet, about one millimeter inside the annulus. After 
closure of the VSD, a separate continuous suture line 7-0 or 6-0 polypropilene was used 
to reattach the leaﬂets. In addition to a right atriotomy, two patients (both non-TVD) 
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required a second approach: one needed an additional left ventriculotomy for an api-
cally situated central muscular VSD, the other an additional pulmonotomy to enhance 
the exposure of an outlet VSD. TVD was used more frequently in the ﬁrst half of the series 
(32 out of 94, 34%) compared to the second half (14 out of 94, 15%).
The type of VSD was ﬁnally determined at the time of surgery: 173 (92%) were peri-
membranous, four inlet (2%), four outlet (2%) and seven central muscular (4%). One VSD 
Table 1: Pre-operative baseline characteristics
n Mean Range
Age 1.8 years 2.5 weeks – 14.8 years
Weight 9.1 kg 2.2 – 49 kg
 Percentile 29 1 –99
Height 0.72 m 0.35- 1.64 m
 Percentile 16 1 – 99
Diuretics 140 (74%)
Decreased exercise tolerance 143 (76%)
Concomitant syndromal anomalies  32
 Down’s syndrome 26 (14%)
 Jacobsen syndrome  1 (0.5%)
 Melas syndrome  1 (0.5%)
 Sotos syndrome  1 (0.5%)
 VACTERL association  1 (0.5%)
Electrocardiogram
 Left ventricular hypertrophy  25 (13%)
 Right ventricular hypertrophy  39 (21%)
 Biventricular hypertrophy  71 (38%)
 A-V-conductance disorders   0
 Wolﬀ Parkinson White syndrome   2 (1.1%) 
Echocardiography
 Tricuspid valve insuﬃciency
   Normal 129 (69%)
   Minimal/trivial  56 (30%)
   Severe   3 (1%)
Catheterization  35 (19%)
Associated cardiac defects
 ASD 103 (55%)
 PAD   5 (3%)
 ASD and PAD  29 (15%)
 Aortic coarctation with ASD and PAD   1 (0.5%)
 Aortic coarctation wit PAD   1 (0.5%)
ASD, atrial septal defect; PAD, patent arterial duct.
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complicated by endocarditis was closed with autologous pericardium, all the others 
were closed with a Gore-Tex® patch. Postoperative echocardiography was performed 
with 2D and color-Doppler and used to assess tricuspid valve function as well as possi-
ble residual shunting. Tricuspid valve regurgitation was graded as none, trivial or severe, 
based on the area and the length of the color jet. Residual shunting was deﬁned as no 
residual shunting as no detectable color jet; trivial residual shunting as a minimal color 
jet and signiﬁcant residual shunting as detectable VSD with an important color jet.
Follow-up concerning the presence of a residual shunting and evaluation of the 
tricuspid valve was complete in 177 patients (95%). Endpoints with respect to residual 
shunts were reoperation for residual VSD or spontaneous closure of the shunt as evalu-
ated by echocardiography at the outpatient clinic. Three patients were lost to follow-up 
because they left the country shortly after operation. Hospital mortality was deﬁned as 
death within 30 days postoperative. The mean follow-up time was 2.6 years (range 0.1 
– 9.4 years).
Statistical analysis
The analysis of categorical variables was performed with X²-test. Continuous variables, 
described as the mean ± standard deviation were analyzed using the independent 
Student’s t-test. Logistic regression analysis was used to analyze predictive values for 
residual shunt at discharge. A signiﬁcant diﬀerence was found when probability values 
were smaller than 0.05.
RESULTS
At operation the group with TVD was younger (mean age 0.8 ± 1.8 (median 0.38) vs 2.1 
± 3.5 years (median 0.41), p = 0.002), had a lower weight (6.5 ± 6.4 vs 10.0 ± 11.0 kg., p 
= 0.009) and were shorter in length (0.63 ± 0.17 vs 0.75 ± 0.31 m, p = 0.004) compared 
to the non-TVD group. There were no signiﬁcant diﬀerences between the two groups 
concerning pre-operative use of diuretics (p = 0.24), failure to thrive (p = 0.29) or exercise 
intolerance (p = 0.14). Cardiopulmonary bypass time was not signiﬁcantly diﬀerent (TVD 
group 62 ± 14 min vs non-TVD group 64 ± 28 min, p = 0.61). The groups also did not dif-
fer in cross-clamp time (TVD 36 ± 11 min vs non-TVD 33 ± 13 min, p = 0.23). Two patients 
died during their hospital stay. One patient (TVD group) with pulmonary hypertension 
died during the operation because of a pulmonary hypertensive crisis. One patient (non-
TVD group) died on the ﬁrst postoperative day in relation to acute patch dehiscence, 
despite an emergency reoperation. One patient needed a resternotomy because of 
persistent blood loss. Two other patients needed prolonged postoperative ventilation 
support (both 10 days) and in two more the sternum was closed secondarily because of 
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initial hemodynamic instability. Because of persistent complete atrioventricular block in 
one patient a permanent VVI-pacemaker was implanted. There were 186 early survivors; 
one patient died 7 months postoperative due to a bronchopneumonia.
The types of VSD in the TVD and non-TVD groups did not diﬀer (perimembranous 
n=43, 93% vs n=130, 92%; inlet n=1, 2% vs n=3, 2%; outlet n=0, 0% vs n=4, 3% and 
central muscular n=2, 4% vs n=5, 4%).
The postoperative echocardiographic assessment of tricuspid valve function was: 
121 patients (64%) had no tricuspid valve regurgitation, 67 patients (36%) had trivial 
regurgitation and none had severe tricuspid valve regurgitation. From the 67 patients 
with trivial/minimal regurgitation 10 (22%) were from the TVD group and 57 (40%) from 
the non-detached group (p = 0.02).
Postoperative echocardiography showed residual shunting in 73 patients, all trivial. 
The median time of echocardiographically proven spontaneous closure was 3.9 years. 
The incidence of a residual shunt did not diﬀer (TVD vs non-TVD 17 vs 56, p=0.48). During 
follow-up 37 (51%) of the residual shunts closed spontaneously. As illustrated in Fig.1 all 
residual shunts are expected to close within 10 years. In a univariate logistic regression 
both lower age and lower weight at operation were predictive of residual shunting at 
hospital discharge (see Table 2). In the multivariate logistic regression only lower weight 
at operation was predictive (odds ratio 0.95, conﬁdence limits 0.91 – 0.99)
At mid-term follow-up there was no signiﬁcant (p = 1.0) diﬀerence in incidence of 
trivial tricuspid valve regurgitation between the non-TVD group (n = 15, 11%) and TVD-
group (n=15, 11%). The presence of left ventricular hypertrophy on electrocardiogram 
was reduced from 25 patients to two (92% reduction); right ventricular hypertrophy was 
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Figure 1. Prediction of residual shunting after surgical closure of a ventricular septal defect.
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reduced from 38 to 4 (89% reduction) and a complete reduction in hypertrophy was seen 
in patients with biventricular hypertrophy (71 patients). Use of diuretics showed a 92% 
reduction (from 127 patients to 10) and failure to thrive and exercise intolerance were 
reduced with 94% (from 134 to 8). The mean weight percentiles increased for the whole 
group from 16 ± 23 to 40 ± 30 as did the mean height percentile: 29 ± 28 to 40 ± 30.
DISCUSSION
Detachment of the tricuspid valve may improve visualization of the margins of a VSD 
and can thereby diminish the chance of a residual shunt, creation of a heart block or 
distortion of the tricuspid valve. Gaynor et al. [9] reported TVD in 21% of the patients in 
closing an isolated VSD, previously we reported 26% [6]. In the present study we used 
TVD in 24% of the patients, in the second half of the series this technique was applied in 
14%. TVD was applied to the surgeons’ choice only in cases with multiple chordal attach-
ments to the rim of the VSD. This study conﬁrms that tricuspid valve detachment can be 
performed without additional complications and does not lead to a longer cross-clamp 
time [6]. Nonetheless, concern exists whether tricuspid valve detachment may lead to 
temporarily or permanent dysfunction of the tricuspid valve. In the long-term, growth 
of the tricuspid annulus might also be impaired, possibly leading to tricuspid valve 
stenosis [10]. In this series detachment of the tricuspid valve did not cause tricuspid 
insuﬃciency or tricuspid stenosis. Postoperative echocardiography showed that tricus-
pid insuﬃciency in the detached group was even considerably lower compared to the 
non-detached group. In the detached group the valve will keep its original strength and 
elasticity. In the non-detached group, however, the valve may experience mechanical 
Table 2. Logistic regression analysis for residual VSD
Univariate
Variable Odds Ratio C.I.
Age 0.86 0.76 – 0.97
Date of operation 1.04 0.93 – 1.15
Weight at operation* 0.95 0.91 – 0.99
Length at operation 0.99 0.97 – 1.00
Detachment of tricuspid valve 0.87 0.43 – 1.74
Female sex 0.99 0.55 – 1.82
Non-perimembranous VSD 0.95 0.32 – 2.78
Cross-clamp time 0.99 0.96 – 1.01
Associated cardiac defect 1.38 0.68 – 2.78
C.I., conﬁdence Interval; VSD, ventricular septal defect
* Signiﬁcant in multivariate analysis.
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stress by stretching the chordae or the leaﬂets that could lead to temporarily insuﬃ-
ciency [9].
With color-Doppler small residual shunts are frequently noted after repair of a 
VSD [5,11,12]. In an earlier study we found an incidence of 20% in this regard [6]. Echo-
cardiography at discharge showed that 73 (39%) of the 186 hospital survivors had a 
trivial residual shunt across the septum, during follow-up in 37 patients the shunt closed 
spontaneously. The exposure of the VSD was improved by TVD, the incidence of residual 
shunting was comparable in the TVD group (N= 56, 40%) and the non-TVD group (n= 
17, 38%). Detachment of the tricuspid valve was not a signiﬁcant factor in relation to 
residual shunting in the logistic regression analysis (OR 0.87; C.I. 0.43 – 1.74). Weight at 
operation was the only independent predictive factor for a residual shunt. The smaller 
the child the more likely a residual shunt existed at discharge. Obviously, in closing a 
VSD in a smaller patient, the balance between prosthesis compliance and tissue friability 
is diﬀerent.
Tatebe et al. [13] in their study concluded that detachment of the tricuspid valve 
should be avoided in patients with Down’s syndrome and small infants because of a 
higher incidence of tricuspid valve regurgitation. In our series 26 patients (nine TVD, 
17 non-TVD) had Down’s syndrome. There was no signiﬁcant (p = 0.613) diﬀerence in 
regurgitation between the TVD group (four patients (44%) with trivial TI) and the non-
TVD group (eight patients (47%) with trivial TI). This suggests that TVD in patients with 
Down’s syndrome can be performed safely.
In contrast to the ﬁnding of Tatebe et al. [13] in the group of small children with 
a pre-operative weight under the 10th percentile (122, 33 detached, 89 non-detached) 
postoperative tricuspid valve regurgitation was signiﬁcantly (p = 0.009) higher in the 
non-detached group (38, 43%) vs the detached group (6, 18%).
Patients with VSD demonstrate satisfactory bodyweight gain after VSD-closure [14]. 
This study also showed an increase in weight and length percentile postoperatively. Total 
energy expenditure is 40% higher in children with a VSD compared to healthy controls 
[15]. This study conﬁrms that closure of a VSD results in a catch-up growth after closure.
This study illustrates that closure of a VSD can be performed with a low compli-
cation rate. Tricuspid valve detachment is a safe method to enhance the exposure of 
a VSD. TVD results in less early postoperative tricuspid valve regurgitation and does 
not result in tricuspid valve dysfunction during follow-up. TVD results in comparable 
residual shunting as non-TVD. The incidence of trivial residual shunting is higher in small 
children irrespective of tricuspid valve detachment. Trivial residual shunting is expected 
to disappear spontaneously.
Follow-up after Surgical Closure of Congenital Ventricular Septal Defect 75
REFERENCES
 [1] Hoﬀman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-
1900.
 [2] Danford DA, Martin AB, Fletcher SE, Gumbiner CH, Cheatham JP, Hofschire PJ, Kugler JD. Children 
with heart murmurs: can ventricular septal defect be diagnosed reliably without an echocardio-
gram? J Am Coll Cardiol 1997; 30: 243-246.
 [3] Gabriel HM, Heger M, Innerhofer P, Zehetgruber M, Mundigler G, Wimmer M, Maurer G, Baumgart-
ner H. Long-term outcome of patients with ventricular septal defect considered not to require 
surgical closure during childhood. J Am Coll Cardiol 2002; 39: 1066-1071.
 [4] Momma K, Toyama K, Takao A, Ando M, Nakazawa M, Hirosawa K, Imai Y. Natural history of subar-
terial infundibular ventricular septal defect. Am Heart J 1984; 108: 1312-1317.
 [5] Maile S, Kadner A, Turina MI, Pretre R. Detachment of the anterior leaﬂet of the tricuspid valve to 
expose perimembranous ventricular septal defects. Ann Thorac Surg 2003; 75: 944-946
  [6] Bol-Raap G, Bogers AJ, Boersma H, De Jong PL, Hess J, Bos E. Temporary tricuspid valve detach-
ment in closure of congenital ventricular septal defect. Eur J Cardiothorac Surg 1994; 8: 145-148.
 [7] Frenckner BP, Olin CL, Bomﬁm V, Bjarke B, Wallgren CG, Bjork VO. Detachment of the septal tricus-
pid leaﬂet during transatrial closure of isolated ventricular septal defect. J Thorac Cardiovasc Surg 
1981; 82: 773-778.
 [8] Bol-Raap G, De Jong PL, Bogers AJ. Temporary tricuspid detachment in closure of ventricular 
septal defect. Ann Thorac Surg 2001; 71: 1067.
 [9] Gaynor JW, O’Brien JE, Jr., Rychik J, Sanchez GR, DeCampli WM, Spray TL. Outcome following tri-
cuspid valve detachment for ventricular septal defects closure. Eur J Cardiothorac Surg 2001; 19: 
279-282.
 [10] Hudspeth AS, Cordell AR, Meredith JH, Johnston FR. An improved transatrial approach to the 
closure of ventricular septal defects. J Thorac Cardiovasc Surg 1962; 43: 157-165. 
 [11] Rychik J, Norwood WI, Chin AJ. Doppler color ﬂow mapping assessment of residual shunt after 
closure of large ventricular septal defects. Circulation 1991; 84: III153-161.
 [12] Yang SG, Novello R, Nicolson S, Steven J, Gaynor JW, Spray TL, Rychik J. Evaluation of ventricular 
septal defect repair using intraoperative transesophageal echocardiography: frequency and sig-
niﬁcance of residual defects in infants and children. Echocardiography 2000; 17: 681-684.
 [13] Tatebe S, Miyamura H, Watanabe H, Sugawara M, Eguchi S. Closure of isolated ventricular septal 
defect with detachment of the tricuspid valve. J Card Surg 1995; 10: 564-568.
 [14] Levy RJ, Rosenthal A, Miettinen OS, Nadas AS. Determinants of growth in patients with ventricular 
septal defect. Circulation 1978; 57: 793-797.
 [15] Ackerman IL, Karn CA, Denne SC, Ensing GJ, Leitch CA. Total but not resting energy expenditure 
is increased in infants with ventricular septal defects. Pediatrics 1998; 102: 1172-1177.

C H A P T E R  8
Long-term Follow-up after Closure of 
Ventricular Septal Defect in Adults
G. Bol Raap, F.J. Meijboom, A.P. Kappetein, T.W. Galema, S.C. Yap, and A.J.J.C. Bogers
Submitted
78
C
ha
pt
er
 8
ABSTRACT
Background. Little is known about the results of surgical closure of a ventricular septal 
defect (VSD) in patients presenting at adult age.
Methods. A retrospective study was carried out of 28 patients (15 male) operated upon 
between 1980 and 2004. Patients were investigated by echocardiography, ECG and 
assessed for quality of life by a questionnaire.
Results. The indication for surgery was volume overload in11 patients, endocarditis in 
8, aortic valve regurgitation in 8 and the combination of a VSD with subvalvular aortic 
stenosis in one. One patient was lost to follow-up after eleven years. Follow-up was com-
plete with a mean duration of follow-up of 13 years. There was no early or late mortality. 
One patient was reoperated for recurrent VSD. Twenty-six patients are in NYHA class I, 
one is in class III. Twenty-ﬁve patients underwent echocardiography and revealed trivial 
residual VSD in 2. One patient had persistent pulmonary hypertension with right ven-
tricular hypertrophy. Mild aortic regurgitation was detected in 10 patients (40%). 
The same twenty-ﬁve patients underwent ECG. One patient was in atrial ﬁbrillation 
and the remainder were in sinus rhythm.
Health related quality of life in the dimensions cognitive functioning and sleep dif-
fered signiﬁcantly from that of the general population.
Conclusion. With a relative diﬀerence in indications for closure of a VSD in adulthood, 
surgical closure of VSD at adult age is an adequate and safe procedure, with good results 
on long-term follow-up. Progression of aortic valve regurgitation is a matter of concern. 
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INTRODUCTION
The majority of isolated congenital ventricular septal defects (VSD) close spontaneously. 
In 80% of the patients with a VSD seen at the age of 1 month, the VSD will close sponta-
neously. Also before closure the majority of these patients were entirely asymptomatic. 
Patients who develop symptoms due to substantial left-to-right shunting are operated 
upon in the ﬁrst year of life [1]. The long-term results of surgical closure of VSD in infancy 
are very good and are well documented in terms of survival, morbidity and quality of life 
[2-4]. In contrast, little is known about surgical VSD closure at adult age.
In patients with a VSD, the clinical course depends on the size of the defect, the 
localisation of the defect and on concomitant anomalies [1]. In young patients the 
indication for surgical closure of a VSD are most often left-to-right shunting related 
symptoms [5]. Surgical closure abolishes the left-to-right shunt, prevents development 
of pulmonary vascular disease, decreases the risk of endocarditis, improves functional 
classiﬁcation and increases long-term survival [6].
If spontaneous closure of a VSD did not occur in childhood or adolescence, the 
chance that it will close in adult life is small. In adults spontaneous VSD closure is 
reported to occur in only 10% of the patients [1, 7, 8]. With advancing age, symptoms 
are related to secondary eﬀects of a shunt, and persistent defects may predispose to 
endocarditis, aortic regurgitation and in selected cases to heart failure, arrhythmias and 
pulmonary hypertension [9]. Very few data exist on indication for VSD closure at adult 
age, on postoperative course and there are almost no data on long-term follow-up of 
patients with a VSD operated upon at adult age [5]. 
Quality of life of patients undergoing surgical closure during childhood is compa-
rable to that of the normal population [3]. For those operated in adulthood this has not 
been studied. Therefore we describe the follow-up, including quality of life of patients 
undergoing surgical closure of a VSD in adulthood.
MATERIAL AND METHODS
A retrospective study was carried out of a consecutive series of 28 adult patients (15 
male, 13 female), operated upon for a single congenital VSD over the age of 16 years 
between January 1980 and January 2004. The mean age at the time of surgical closure 
was 34 years (range 19-50 years). Excluded were patients with other cardiac anomalies 
aﬀecting the ventricular septum. 
Diagnosis and hemodynamic assessment was performed by echocardiography. In 
the early part of the series, before ultrasound was available for clinical use, diagnosis was 
conﬁrmed with cardiac catheterization in 14 patients.
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All patients were operated with cardiopulmonary bypass. The mean extracorporeal 
circulation time was 76 minutes (range 37-124 minutes) and the mean aortic cross-
clamp time 43 minutes (range 20-87 minutes). In 7 patients one or more concomitant 
anomalies were treated. In one the aortic valve was replaced by a mechanical valve, in 
2 a secundum atrial septal defect (ASD) was primarily closed, in one a persistent arterial 
duct was ligated and in one patient both a secundum ASD was closed and a persis-
tent arterial duct was ligated. In one patient a stenosis of the left pulmonary artery was 
treated with patch augmentation with autologous pericardium and in one a discrete 
subaortic stenosis was enucleated. See Table 1.
A right atrial approach to the VSD was used in 27 patients. An additional right 
ventriculotomy and an additional aortotomy were performed in 2, and an additional 
pulmonotomy in one patient. An exclusively right ventriculotomy was used in only one. 
To improve the exposition of the VSD the septal leaﬂet of the tricuspid valve was tempo-
rarily detached in 2 patients [10, 11].
Closure of the VSD was performed either with a Gore-Tex® patch (n=13, 46%), a 
Dacron® patch (n=8, 29%), a pericardial patch (n=5, 18%) or primarily (n=2, 7%). See 
Table 1.
Table 1 Patient and Operation Characteristics
n =28 % Mean Range
Cross Clamp time (mean, range) 43 20-87
Bypass time (mean, range) 76 37-124
Concomitant anomalies  7 25
 Atrial septal defect (secundum type)  2
 Persistent arterial duct  1
 Persistent arterial duct and atrial septal defect (secundum type)  1
 Discrete subaortic stenosis  1
 Stenosis left pulmonary artery  1
Indication for Surgery
 Left to right shunt>1.5 12 42
 Endocarditis  8 29
 Aortic regurgitation  8 29
Method of closure
 Gore-Tex patch 13 46
 Dacron patch  8 29
 Pericardial patch  5 18
 Primarily  2  7
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One patient went abroad 11 years post-operatively in good clinical health and 
was included as lost to follow-up from that time on. Two patients, who were in good 
clinical health, refused to undergo echocardiography and ECG. They agreed in being 
interviewed by telephone. All 25 remaining patients were seen at our outpatient clinic 
with a mean follow-up time of 13 years. Patients underwent echocardiography, ECG and 
quality of life assessment. Echocardiographic data were analyzed by one cardiologist. 
Echocardiographic data were available for 25 patients, and included chamber dimen-
sions, valve regurgitations, pulmonary systolic pressure, and ﬂow through a residual 
VSD. Quantiﬁcation of the chamber dimensions was performed according to the ASE 
guidelines [12]. Regurgitant severity of the aortic, pulmonary, and tricuspid valve was 
graded as none/trivial to severe (0 to 4+) on the basis of color ﬂow imaging [13]. Pulmo-
nary systolic pressures were calculated on the basis of tricuspid regurgitant jet veloci-
ties and estimated right atrial pressures using inferior vena caval dimension [12, 13]. A 
pulmonary systolic pressure > 35 mmHg was considered pulmonary hypertension. 
The electro-cardio graphic data were also analysed by one cardiologist. 
Health related quality of life was determined with the TAAQOL-questionnaire [14]. 
It consists of 45 questions divided into 12 domains. Each domain contains two to four 
questions (the actual number per domain is given in parentheses): gross motor func-
tioning (4), ﬁne motor functioning (4), pain (4), sleeping (4), cognitive functioning (4), 
social functioning (4), daily activities (4), sexual activity (2), vitality (4), happiness (4), 
depressive moods (4), and aggressiveness (3). Scores of each subscale are normalised 
to a scale ranging from 0 to 100, with higher scores indicating better quality of life. For 
each item, the frequency of occurrence of a health status problem is assessed. If such a 
problem is reported, the emotional reaction to this problem is also determined [14, 15]. 
TAAQOL data of the Dutch general population are available [14].
Categorical variables, summarized in terms of relative frequencies, were analysed using 
the chi-square test with the Yates correction or using Fisher’s exact test. Continuous 
variables, described as the mean and range, were analysed using Student’s t-test. P-val-
ues < 0.05 were considered signiﬁcant. The participants' health related quality of life (as 
measured by the TAAQOL) was compared with that of a random sample of the general 
Dutch population in 4410 persons using analysis of variance with adjustment for age 
and sex. After comparison, the data were summarised as mean values and 95% conﬁ-
dence intervals.
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RESULTS
Indications for surgical closure of the congenital ventricular septal defect were substan-
tial left-to-right shunt (12/28, 42%), endocarditis (8/28, 29%) and aortic regurgitation 
(8/28, 29%).
Seven of the 12 patients with a substantial left-to-right shunt presented relatively 
late and were in NYHA class II. Of these, 2 patients (2/7) came from developing countries 
and in two others the parents of the patients had declined diagnostic procedures at 
pediatric age. The remaining three patients came from referring centres and were pre-
sented late; one patient with pulmonary hypertension, one had Down’s syndrome and 
the third was not operated upon in the past because of presumed high operative risk.
The indication for surgical closure was endocarditis in 8 patients (29%). In none of 
these patients the VSD was haemodynamicilly important. In 4 patients it concerned an 
endocarditis lenta and in 4 the VSD was closed after successful medical treatment of a 
second episode of endocarditis. Identiﬁed organisms were Streptococcus Viridans (2), 
Streptococcus Mutans (1), Enterococcus Faecalis (1), Streptococcus species with unde-
termined isotype (3) and Staphylococcus Aureus (1). Endocarditis was more prevalent in 
males than in females (7 vs. 1). 
Progressive aortic valve regurgitation was the indication for closing a perimembra-
neous ventricular septal defect in 8 other patients (29%). In one patient the aortic valve 
was replaced, in 2 a fenestration in the right coronary cusp was closed, and in 5 a mild 
aortic regurgitation was left untreated. 
At presentation 17 patients (61%) were in NYHA class I and 11 (39%) in NYHA class 
II. 
At surgery the VSD was found to be perimembraneous in 24 (86%), outlet type in 2 
(7%) and muscular in 2 (7%).
Early postoperative complications were mediastinal exploration for persistent blood 
loss in 3 and adult respiratory distress syndrome in one patient.
Follow-up
Follow-up was complete in 27 patients with a mean duration of 13 years (range 1 - 23 
years). No patient died. One patient was reoperated because of a residual VSD 2 years 
after the initial procedure, in which the indication was aortic regurgitation. No recurrent 
episodes of endocarditis were reported.
At last follow up, 26 of the 27 patients were in NYHA class I. One patient, preopera-
tively in NYHA class II with pulmonary hypertension, was in NYHA class III still suﬀering 
from pulmonary hypertension. In addition she was in atrial ﬁbrillation. 
Echocardiographic ﬁndings at follow-up are listed in table 2. Tricuspid regurgitation 
grade 1+ was present in 8 (32%) patients and grade 2+ in 4 (16%) patients, including 
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the patient with pulmonary hypertension. No tricuspid regurgitation was present in the 
two patients with temporary tricuspid valve detachment. The aortic valve was normal in 
15 (60%) patients, grade 1+ aortic regurgitation was present in 9 (36%) and grade 2+ in 
one (4%) patient. Six of the 8 patients in whom the indication for closure of the VSD was 
aortic regurgitation had grade 1+ aortic insuﬃciency at follow-up, the other 2 had no 
aortic insuﬃciency. Left ventricular dilatation was present in 7 (28%) patients, in all but 
one (6/7) the indication for closure of the VSD was a left-to right shunt. 
The electro-cardiographic data revealed that one patient was in atrial ﬁbrillation, all 
other were in sinusrhythm (96%). The mean PQ-interval for the patients in sinusrhythm 
Table 2 Echocardiographic ﬁndings at a mean follow-up of 12 years postoperatively
Echocardiographic variables N=25
Residual VSD  2 (8%)
Peak velocity residual VSD (m/s)  4.6±0.7
Left atrium (mm) 39±8
Left atrial dilatation (>40 mm) 12 (48%)
LV end-diastolic diameter (mm) 52±7
LV dilatation (>55 mm)  7 (28%)
LV end-systolic diameter (mm) 35±6
Fractional shortening (%) 32±6
Fractional shortening<25%  3 (12%)
Interventricular septum (mm) 10±2
LV posterior wall (mm)  9±2
RV diameter (mm) 39±5
Tricuspid regurgitation
 None/ trivial 13 (52%)
 1+  8 (32%)
 2+  4 (16%)
Pulmonary regurgitation
 None/ trivial 18 (72%)
 1+  4 (16%)
 2+  3 (12%)
Aortic regurgitation
 None/ trivial 15 (60%)
 1+  9 (36%)
 2+  1 (4%)
Peak velocity tricuspid regurgitation (m/s)  2.2±0.4
Pulmonary hypertension (>35 mmHg)  1 (4%)
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was 160 ms (126-232). The mean duration of the QRS-complex was 107 ms (72-148), 
QT-interval 390 ms (350-460) and QTc was 411 ms (353-489).
In seven patients (26%) the ECG showed a right bundle branch block. One patient 
with a right bundle branch block was also in atrial ﬁbrillation. None of the patients had 
signs of sinus node dysfunction, none had a complete A-V block.
Figure 1 gives the average TAAQOL scores of the patients compared to the general 
population sample. The patients had signiﬁcantly lower health related quality of life in 
cognitive functioning (score 74 vs. 83 in controls, p<0.045) and sleep (60 vs. 74 in con-
trols p<0.006).
Scores of each subscale are normalised to a scale ranging from 0 to 100, with higher 
scores indicating better quality of life.
DISCUSSION
This study shows that surgical closure of a congenital VSD at adult age can be done 
without mortality and without major early or long-term complications. Nevertheless, 
some residual lesions were found, e.g. one patient with substantially elevated RV-pres-
sure indicating pulmonary vascular disease due to long-standing pulmonary overﬂow 
had persisting pulmonary hypertension after the operation. Moreover, in the group of 
patients operated upon because of clinically important left-to-right shunting, 7 out of 
25 patients (28%) had signs of persisting left ventricular dilatation. In none of these 
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Figure 1. Quality of life in diﬀerent domains compared to the average Dutch population
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patients there were signs left ventricular failure up to 24 years after surgery. This seems 
to indicate that avoiding of development of left ventricular failure is achieved by surgi-
cal closure of the VSD. However, continued long-term follow-up is necessary to further 
substantiate this.
More important is the ﬁnding that a substantial portion of patients operated upon 
at adult age did not show a normalisation of intra-cardiac dimensions after VSD closure, 
which is hardly ever seen after surgical closure of a VSD in childhood. The long-term 
follow-up after surgical closure of a VSD in infancy is documented extensively [2-4] in 
contrast to surgically VSD closure at adult age. This suggests that these patients prob-
ably would have beneﬁted from an earlier operation.
In addition to closure of the VSD, one patient had aortic valve replacement 18 years 
after initial indication for closure at the age of 12 years, when the parents refused the 
operation. In none of the remaining 7 patients, for whom indication for surgical closure 
was a subaortic, perimembranous localisation of the VSD in combination with develop-
ment of aortic regurgitation, aortic regurgitation progressed to a degree beyond mild. 
In the natural history of these defects development of moderate or even severe aortic 
regurgitation is reported to be frequent [7]. These results show once more that surgery 
without mortality may be a preferable option for these patients.
The prevalence of arrhythmia in this study – less than 10% of the study population- 
is in line with that of other reports [7]. Theoretically, atrial ﬁbrillation can be expected 
in those patients with long-standing left atrial dilatation due to substantial left-to-right 
shunting. Arrhythmias, ascribed to intracardiac surgery performed through a right atrial 
incision, due to a “macro” re-entry tachycardia around the surgical scar, presenting as 
atrial ﬂutter are rare. This might indicate that the theoretically pro-arrhythmogenic sur-
gical right atrial scar does not lead to clinically signiﬁcant arrhythmias up to 24 years 
after surgery. It is evident that longer follow-up is necessary in this matter.
Quality of life of this operated adult VSD group is comparable with general popu-
lation. In 10 out of twelve domains they had an equal score. In 2 domains, cognitive 
functioning and sleep, our population diﬀered from the general population with regard 
to the quality of life. This can be interpreted as the quality of life of our patient group 
being practically equal to the normal population.
Looking at the very good results in terms of mortality and complication rate of sur-
gical closure of VSD’s at adult age, realizing that patients operated upon because of left-
to-right shunting might had beneﬁted from earlier surgery and knowing the cumulative 
risk of endocarditis in this population of over 10% [7] with a mortality rate of 15-25% [7, 
16, 17] even in the modern era of sophisticated antibiotic therapy, one might consider 
closure of all VSD’s that have not closed spontaneously in the ﬁrst 2 decades of life.
Apart from these considerations, the results of this study provide a benchmark for 
the emerging experience of device closure of a VSD [18].
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ASPECTS OF DIAGNOSIS
Ample information is available concerning, anatomy, (patho-) physiology, clinical course, 
diagnostic tools and surgical therapy of the congenital ventricular septal defect. With 
regard to echocardiographic diagnosis, only recently 3D echocardiography and addi-
tionally virtual reality 3D echocardiography, is starting to build up.
Preoperatively, 3D echocardiography shows an accurate view of the anatomy of the 
VSD with a good intra-and interobserver reproducibility and reveals that the functional 
anatomy of the tricuspid valve, the right ventricular outﬂow tract, and the aortic valve 
can be displayed in their actual spatial distribution. Besides anatomy, pathophysiology 
of a VSD is a critical factor in management decisions, pulmonary vascular resistance 
being an important factor in the shunting of the VSD. At present, analytic methods to 
assess shunt size are lacking for 3D echocardiography and therefore also for virtual real-
ity 3D echocardiographic analysis.
Currently, I-Space technology is only available in a limited number of research cen-
tres throughout the world. Therefore, the representation and analysis of 3D echocar-
diography datasets by virtual reality has only been described very recently. As a new 
application, virtual reality is extended to postoperative control of the results of surgery 
for congenital VSD, in datasets derived epicardially. An important ﬁnding is that motion 
abnormalities of the tricuspid valve leaﬂets were found, that were not appreciated in 2D 
echocardiography. Virtual reality provided a unique resource for postoperative quality 
control as well as for education with regard to the intracardiac repair of congenital VSD. 
The virtual reality analysis can be done by the practical expert in the relevant anatomy, 
for instance the cardiothoracic surgeon performing the operation, and depends to a 
lesser extent on the expert in echocardiographic imaging, for instance the cardiologist 
making the diagnosis. Virtual reality in this regard provides an additional resource for 
postoperative quality control as well as for education with regard to the intracardiac 
repair of congenital VSD.
With the growth of minimal invasive cardiac surgery and interventional procedures, 
the interest for simulation by a hologram of the area of interest as a training tool will 
increase. In this regard both the area of interest before surgery or intervention as well as 
the result after therapy can be analysed and compared. 
With the I-Space technology, the complex postoperative cardiac anatomy of the 
closed congenital VSD can be appropriately visualised in virtual reality. 
3D technology is evolving towards smaller, cheaper, and more ﬂexible 3D visualiza-
tion and interaction systems with greater resolution. 
Indeed, virtual reality 3D echocardiography should be able to run on smaller sys-
tems, either based on miniaturization of the system (desktop format, either oﬀ location 
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or on top of the echomachine) or advanced projection (adapted aviation helmet screen 
projection or advanced monitor screen). 
In this way, virtual reality is no longer restricted to VR specialists in VR centers. Desk 
top applications then allows 3D visualization and interaction to be accessible not only 
to engineers, but to all scientists working with 3D and 4D data. 
Moreover, desktop systems and I-space VR systems can be used as complementary 
tools. Scientists are able to design applications for the virtual reality on the desk top 
modality in their oﬃce. Users of 3D and 4D data sets will no longer exclusively need a VR 
system for the analysis of their data, but can apply them both for speciﬁc matters and 
questions.
ASPECTS OF SURGERY
Surgery is the gold standard in closure of a congenital ventricular septal defect. It is 
associated with low mortality and morbidity and is well established, especially in young 
patients, resulting in a correspondingly long life expectancy. Recently, percutaneous 
devices were introduced for closure of a congenital ventricular septal defect. The tech-
nique of device closure has been shown to be feasible but extensive experience is lack-
ing. Closing the VSD with a device may also limit the treatment of associated anomalies 
that need surgical correction. 
Longer and more extensive observation is necessary to determine whether or not 
percutaneous closure will be an alternative for the surgical closure or should be per-
formed in selected patients.
Despite the well-established results of surgery for congenital ventricular septal 
defect, improvements with intraoperative conditioning can be investigated. Surgical 
closure of a VSD in small patients with body weight less than 10 kg. is often performed 
with moderate (28°C) systemic hypothermia. We investigated whether or not this clo-
sure could also be safely performed with mild (32°C) hypothermia. This in relation to 
surgical exposure, myocardial protection, renal function, ventilatory support and the 
ﬁbrinolysis. No diﬀerences were found, the conclusion was made that mild hypothermia 
is safe in closure of a congenital ventricular septal defect in our setting.
Temporary tricuspid detachment is an attractive surgical alternative for the repair 
of a congenital VSD in patients in whom transatrial exposure of the VSD is incomplete. 
This procedure turned out to be associated with patients that were younger, lower in 
weight, shorter and more often on diuretic therapy. This was, however, not reﬂected in a 
worse functional class. Apparently temporary chordal detachment is applicable as well, 
but, arguments in favour, however, should preferably come from obvious advantages or 
from careful follow-up, as does any alternative approach.
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We observed this population for a long period with special emphasis to residual 
shunt and impairment of the tricuspid valve in relation with detachment or not. In the 
long term, growth of the tricuspid annulus might be speculated to be impaired, possibly 
leading to tricuspid valve stenosis. In this series detachment of the tricuspid valve did 
not cause tricuspid insuﬃciency or tricuspid stenosis, both early postoperative as well 
as on long term follow up.
With color-Doppler small residual shunts are frequently noted after repair of a VSD. 
Weight at operation was the only independent predictive factor for a residual shunt. The 
smaller the child the more likely a residual shunt existed at discharge. Obviously, in clos-
ing a VSD in a smaller patient, the balance between prosthesis compliance and tissue 
friability is diﬀerent. Because the clinical condition of the patient determines the timing 
of surgery, it can be accepted that in young patients the trivial residual shunt may have 
an increased incidence. In this perspective, the fact that this study conﬁrms that closure 
of a VSD results in a catch-up growth after closure is not to be neglected.
Trivial residual shunting is expected to disappear spontaneously, for this reason one 
should reconsider to subject a patient with a residual shunt after closure of a VSD on 
lifelong endocarditis-prophylaxis. For this reason, these patients can only be discharged 
from follow-up after complete closure of the residual shunt. 
FOLLOW UP
The long-term follow-up after surgically VSD closure in infancy is well documented with 
respect to survival, morbidity and quality of life in contrast to surgically VSD closure at 
adult age. 
Concerning the quality of life, our study conﬁrms that quality of life of this adult VSD 
group is comparable with that of the general population. Quality of life testing with the 
TAAQOL questionnaire showed that in 10 out of twelve domains they had an equal score 
as in general population. In 2 domains, cognitive functioning and sleep, our population 
diﬀered from the general population with regard to the quality of life.
Concerning the very good results in terms of mortality and complication rate of 
surgical closure of a congenital VSD at adult age and realizing that patients operated 
upon because of left-to-right shunting might had beneﬁted from earlier surgery and 
knowing the cumulative risk of endocarditis in this population we conclude that, even 
in the modern era of sophisticated antibiotic therapy, one might consider closure of all 
VSDs that have not closed spontaneously in the ﬁrst 2 decades of life.
Apart from these considerations, the results of our study provide a benchmark for 
the emerging experience of device closure of a VSD.
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SUMMARY
In Chapter 1, an outline of the thesis is given. This thesis focuses on aspects of surgical 
closure of a congenital ventricular septal defect. 
In Chapter 2, the accuracy and the potential of 3D echocardiography in the preopera-
tive assessment of a congenital VSD were evaluated. 3D echocardiography can be con-
sidered a valuable diagnostic tool, which may accurately identify the location, size, and 
spatial relations of a VSD. 
Chapter 3 presents a surgical alternative by temporary tricuspid valve detachment, in 
the approach for the repair of a congenital VSD in patients in whom transatrial exposure 
of the VSD is inadequate. The procedure was signiﬁcantly associated with patients that 
were younger, lighter in weight, shorter and more often on diuretic therapy. Regardless 
of the age, size and preoperative clinical condition of the patients, and regardless of the 
right ventricular load, temporary detachment of the tricuspid valve in closure of a con-
genital VSD can be performed safely, without any negative eﬀect on growth or function 
of the valve at medium-term follow-up.
Chapter 4 comments on temporary chordal detachment as an alternative to temporary 
detachment of the anterior or septal tricuspid leaﬂet from the tricuspid annulus in repair-
ing a congenital VSD in patients in whom transatrial exposure of the VSD is incomplete. 
This technique may be useful in selected cases; however, arguments in favour should 
preferably come from obvious advantages or from careful follow-up.
Chapter 5 focuses on the diﬀerences between mild (32°C) and moderate (28°C) systemic 
hypothermia during the reconstruction of a congenital ventricular septal defect in pae-
diatric patients. No diﬀerences were found regarding organ preservation and adequacy 
of cardio pulmonary bypass, nor in surgical exposure and clinical outcome. 
Chapter 6 demonstrates the clinical application of real time 3D echocardiography in 
patients with a surgically corrected congenital ventricular septal defect. With I-Space 
technology, the complex postoperative cardiac anatomy of the closed congenital VSD 
can be appropriately visualised in virtual reality and provides a unique resource for post-
operative quality control as well as for education with regard to the intracardiac repair 
of a congenital VSD.
Chapter 7 provides a long-term follow-up study after surgical closure of a congenital 
ventricular septal defect. To enhance surgical exposure of the congenital ventricular 
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septal defect in selected patients, the tricuspid valve was temporary detached from the 
tricuspid annulus and proved to be a safe method. Closure of a congenital ventricular 
septal defect can be performed with a low complication rate. Tricuspid valve detach-
ment (TVD) results in less early postoperative tricuspid valve regurgitation and does 
not result in tricuspid valve dysfunction during follow-up. TVD results in comparable 
residual shunting as non-TVD. The incidence of trivial residual shunting is higher in small 
children irrespective of tricuspid valve detachment. Trivial residual shunting is expected 
to disappear spontaneously
Chapter 8 provides a long-term follow-up study after surgical closure of a congenital 
ventricular septal defect at adult age with special emphasis to quality of life. The need 
for surgical closure of a congenital ventricular septal defect in adulthood is rare, but on 
the right indication, surgery is an adequate and safe procedure, with good results on 
long-term follow up. Quality of life of this adult VSD group is comparable with general 
population. In 10 out of twelve domains of the TAAQOL-questionnaire they had an equal 
score. Merely in 2 domains, cognitive functioning and sleep, our population diﬀered 
from the general population with regard to the quality of life. The question is raised 
whether or not all ventricular septal defects at adult age should be closed.
Chapter 9 contains a general discussion regarding aspects of surgery of a congenital 
ventricular septal defect at paediatric and adult age.
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SAMENVATTING
In Hoofdstuk 1 wordt een overzicht gegeven van het proefschrift. Dit proefschrift 
behandelt aspecten van chirurgie voor een aangeboren ventrikel septum defect.
In Hoofdstuk 2, worden de betrouwbaarheid en de mogelijkheden van 3D echocardio-
graﬁe in de preoperatieve analyse van een aangeboren ventrikel septum defect geëva-
lueerd. 3D echocardiograﬁe kan beschouwd worden als een waardevol diagnostisch 
instrument, waarmee nauwkeurig de locatie, de grootte en de ruimtelijke verhoudingen 
van een VSD kunnen worden geïdentiﬁceerd.
Hoofdstuk 3 beschrijft het tijdelijk losmaken van de tricuspidalisklep uit de annulus als 
chirurgisch alternatief in de benadering om een aangeboren ventrikel septum defect te 
sluiten bij patiënten waar de transatriale expositie van het VSD onvoldoende is. Deze 
techniek werd signiﬁcant vaker toegepast bij patiënten die jonger, lichter in gewicht en 
kleiner waren en die vaker diuretica gebruikten. Ongeacht de leeftijd, lengte en gewicht 
en preoperatieve klinische conditie van de patiënten en ongeacht de rechter ventrikel 
belasting kon het tijdelijk losmaken van de tricuspidalisklep uit de annulus bij het slui-
ten van een aangeboren VSD veilig worden uitgevoerd, zonder nadelige eﬀecten op de 
groei of functie van de tricuspidalisklep op middellange termijn.
Hoofdstuk 4 becommentarieert het tijdelijk losmaken van de aanhechting van de 
chordae als een alternatief voor het tijdelijk losmaken van de anterieure of septale 
tricuspidalisklepslip uit de tricuspidaalklep annulus in de chirurgische benadering om 
een aangeboren ventrikel septum defect te sluiten bij patiënten waar de transatriale 
expositie van het VSD onvoldoende is. Deze techniek kan toegepast worden in geselec-
teerde patiënten; echter de argumenten hiervoor zouden bij voorkeur moeten komen 
van duidelijke voordelen of van zorgvuldige follow-up.
Hoofdstuk 5 legt zich toe op de verschillen tussen milde (32°C) en matige (28°C) syste-
mische hypothermie gedurende de reparatie van een aangeboren ventrikel septum 
defect bij kinderen. Er werden geen verschillen gevonden in orgaan bescherming en 
de werking van de cardio pulmonale bypass, noch in chirurgische expositie, noch in 
klinische uitkomst.
Hoofdstuk 6 demonstreert de klinische toepassing van real time 3D echocardiogra-
ﬁe bij patiënten met een chirurgisch gesloten ventrikel septum defect. Met behulp 
van I-space technologie kan de complexe postoperatieve cardiale anatomie van het 
gesloten aangeboren ventrikel septum defect naar behoren gevisualiseerd worden in 
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virtual reality. Bovendien voorziet deze techniek in een unieke bron voor postoperatieve 
kwaliteitscontrole en voor demonstratie met betrekking tot de intracardiale correctie 
van een aangeboren ventrikel septum defect.
Hoofdstuk 7 bespreekt lange termijn follow-up na chirurgische correctie van een 
aangeboren ventrikel septum defect. Om bij geselecteerde patiënten de chirurgische 
expositie te verhogen van het aangeboren ventrikel septum defect, werd tijdelijk de 
tricuspidalisklep uit de annulus losgemaakt en dit bleek een veilige methode. Chirur-
gische correctie van een aangeboren ventrikel septum defect kan worden verricht met 
een lage kans op complicaties. Het tijdelijk losmaken van de tricuspidalisklep uit de 
annulus resulteert in minder vroege postoperatieve tricuspidalisklepinsuﬃciëntie en 
resulteert niet in tricuspidalisklep dysfunctie tijdens follow-up. Het tijdelijk losmaken 
van de tricuspidalisklep uit de annulus resulteert in een vergelijkbare incidentie van 
restshunting als bij niet losmaken van de tricuspidalisklep uit de annulus. De incidentie 
van een onbelangrijke restshunt is hoger bij kleine kinderen, ongeacht het wel of niet 
tijdelijk losmaken van de tricuspidalisklep uit de annulus. Verwacht kan worden dat de 
onbelangrijke restshunt uiteindelijk spontaan zal verdwijnen.
Hoofdstuk 8 bespreekt een lange termijn follow-up studie na chirurgische correctie van 
een aangeboren ventrikel septum defect op volwassen leeftijd met speciale aandacht 
voor de kwaliteit van leven. De noodzaak voor chirurgische correctie van een aange-
boren ventrikel septum defect op volwassen leeftijd is er zelden, maar op de juiste 
indicatie, blijkt chirurgie een adequate en veilige procedure met goede lange termijn 
resultaten. De kwaliteit van leven van deze volwassen VSD groep is vergelijkbaar met die 
van de algemene populatie. In 10 van de 12 domeinen van de TAAQOL-vragenlijst had-
den ze dezelfde score. Slechts in 2 domeinen, cognitief functioneren en slaap, verschilde 
onze VSD groep met die van de algemene populatie met betrekking tot kwaliteit van 
leven. De vraag kan gesteld worden of niet alle ventrikel septum defecten op volwassen 
leeftijd gesloten dienen te worden.
Hoofdstuk 9 bevat een algemene discussie met betrekking tot aspecten van chirur-
gie voor een aangeboren ventrikel septum defect op kinderleeftijd en op volwassen 
leeftijd.
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Een proefschrift is uiteindelijk een gevolg van jarenlange sociale en professionele  vor-
ming. Het begint met de sociale vorming tijdens de jeugd en wordt uiteindelijk geac-
centueerd tijdens de professionele ontwikkeling.
Ik richt mijn dankwoord aan een groot aantal mensen, die op enigerlei manier in ver-
schillende fases van de totstandkoming van dit boekje belangrijk voor mij zijn geweest. 
Ik realiseer me dat ik mogelijk een aantal mensen te kort doe of vergeet, maar zij weten 
zelf welke bijdrage zij direct, dan wel indirect geleverd hebben aan de vorming van de 
persoon die ik ben.
Dit proefschrift is een uitvloeisel van teamwerk en teamgeest van de afdeling Tho-
raxchirurgie aan het Erasmus MC te Rotterdam en is een illustratie van de cohesie bin-
nen de thoraxchirurgische staf.
Hooggeleerde heer Bogers, beste Ad, het is gelukkig niet zo dat jij met deze titulatuur 
wenst te worden aangesproken, maar voor mij is het een manier om mijn respect voor 
jou en jouw manier van werken uit te drukken. Jij bent de motor en grote inspirator 
achter dit proefschrift. Als student-assistent kwam ik binnen op de afdeling net nadat 
jij daar als staﬂid was aangesteld. Als keuze co-assistent heb ik toen onder jouw lei-
ding mijn eerste artikel kunnen schrijven. Ik heb mijn opleiding afgerond en ben direct 
aansluitend aangesteld als staﬂid binnen jouw afdeling als cardio-thoracaal chirurg. 
Vervolgens heb jij mij in staat gesteld mezelf niet alleen professioneel, maar ook in bre-
dere zin te ontwikkelen. Ad, het moge duidelijk zijn, mijn dank voor je vertrouwen en 
vriendschap is groot.
Weledelzeergeleerde heer Kappetein, beste Arie Pieter, samen het bestuur vormend van 
de juniorkamer van de Nederlandse Vereniging voor Thoraxchirurgie is onze samenwer-
king begonnen. Deze heeft de basis gelegd voor onze vriendschap. Vele en lange avon-
den hebben we doorgebracht ﬁlosoferend over het vak en “het leven”, waarbij je ook 
Ineke en de kinderen niet vergat. Ik ben er trots op dat jij mijn co-promotor wilt zijn.
Hooggeleerde heer Haas, beste Felix, tijdens de EACTS in Leipzig in 2004 was onze eerste 
kennismaking. Dit was een paar maanden voor jouw aanstelling als kinderhartchirurg in 
Utrecht. Het feit dat jij als Duitser met een Nederlands voetbalteam aantrad tegen jouw 
“Heimat” en deze wedstrijd winnend afsloot zegt voldoende over jouw persoonlijkheid. 
Hooggeleerde heer de Feyter, beste Pim, als assistent kreeg ik van mijn collegae assi-
stenten reeds te horen “voor een complex klinische casus waarbij je een PTCA overweegt 
moet je bij de Feyter zijn”. Dat klopt en daar heb ik jarenlang mijn voordeel mee gedaan. 
Ik heb veel van je geleerd, ook dat geen interventie goed voor een patient kan zijn.
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Hooggeleerde heer Helbing, beste Wim, jouw heldere kritiek tijdens de Anatomie-Tera-
tologie bespreking heb ik ter harte genomen en was welkome bagage in de voorberei-
ding van dit proefschrift en deze promotie.
Hooggeleerde heer Mochtar, beste Bas, als student-assistent heb ik mijn eerste schreden 
kunnen zetten binnen de afdeling Thoraxchirurgie met jouw proefschrift als entree. Op 
een middag kwam jij jouw kamer binnen en vroeg of ik een harttransplantatie wilde 
zien. Het onbeschrijﬂijke gevoel dat ik rond die operatie had, heeft mede mijn ambitie 
bepaalt om thoraxchirurg te willen worden.
Hooggeleerde heer Klein, beste Jan, jij kwam destijds als nieuw hoofd Thoraxanaesthe-
siologie vanuit het toenmalige Clara ziekenhuis in het Thoraxcentrum werken. Dat was 
toen een goede zet. Ook al ben jij afdelingshoofd Anesthesiologie geworden, jij hebt 
jouw afdeling veel elan meegegeven, niet alleen vakinhoudelijk, maar zeer zeker ook 
qua sfeer. Het is helemaal niet verkeerd om af en toe nog eens aan het werk te gaan in 
het Thoraxcentrum.
Weledelzeergeleerde heer Meijboom, beste Folkert, dank voor de opbouwende kritiek 
op mijn manuscript. Het heeft even geduurd en er zijn verschillende versies van manus-
cripten over heen gegaan, maar met jouw heldere en logische visie op het geheel heb jij 
de “ﬁnetuning” fraai kunnen reguleren.
Het bijzondere van mij en mijn collegae cardio-thoracaal chirurgen is dat we maten zijn, 
in de ware zin van het woord. Niet alleen op de werkvloer maar ook daar buiten vormen 
wij een groep waarin er zonodig kritiek is, maar waar onderling vertrouwen, steun en 
loyaliteit groot zijn. Reden genoeg om jullie individueel dank te zeggen.
Weledelgeleerde heer Maat (what is in a name? ), beste Lex, wat een genoegen dat jij 
mijn paranimf bent. September 1992 kwam er een plek vrij als agnio Thoraxchirurgie. 
Jij was immers per die datum aangesteld als staﬂid. Toen al werd de gezellige toon 
gezet met onder andere een onvergetelijk optreden een onzer collegae in het “duistere” 
Amsterdam. Lex, ik hoop dat ik nu mijn stokje (lees:boekje) aan jou mag overdragen.
Weledelgeleerde heer Bekkers, beste Jos, mijn baken in de afdeling. Geweldig hoe jij mij 
de aorta- en transplantatie chirurgie hebt eigen gemaakt. Ook buiten de kliniek hebben 
we veel gemeen (Feyenoord), maar ook veel niet gemeen: zweefvliegen! Ik laat in het 
midden bij wie het vliegtuigje schoon blijft…. .
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Weledelgeleerde heer Kik, beste Charles, jij bent het bewijs dat bijna al het goede uit 
Rotterdam komt. Ik dacht namelijk dat je uit Groningen of Twente zou komen. Blijkt dat 
je in Schiedam geboren bent! Je blijft me verbazen, maar in het positieve: ﬁjne collega, 
goed mens, loyaal.
Weledelgeleerde heer de Jong, beste Peter, van jouw klinische blik heb ik enorm veel 
opgestoken. Ook buiten de kliniek heb je vaak een heldere visie, welke tijdens onze 
vele tennis- en squash avonden werd geventileerd. Hopelijk kunnen we vanaf juni aan-
staande onze sportieve bezigheden een positieve impuls geven.
Weledelgeleerde heer Meijer, beste Ronald, als co-assistent Heelkunde meldde jij je in 
Alkmaar, waar ik mijn vooropleiding deed. Het doet me deugd dat je nog meer van me 
wilde leren en dus naar Rotterdam toog. Het komt wel goed met jou.
Hooggeleerde heer van Herwerden, beste Lex, doorzetter pur sang. Niet alleen het 
reconstrueren van een mitralisklep heb ik van je geleerd, maar ook dat deze sessies 
gepaard dienen te gaan met een ontspannen sfeer op de operatiekamer. Jouw acuut 
staken van het door jou zo geliefde roken van een sigaretje is slechts een voorbeeld van 
jouw doorzettingsvermogen.
Hooggeleerde heer Bos. Dank voor het in mij gestelde vertrouwen, eerstens als super-
visor van de hartkleppenbank en vervolgens voor de opleiding thoraxchirurgie.
Paul Schoof, Sandeep Singh, Thom de Kroon, Robert Klautz en Jolanda Kluin, cardio-
thoracaal chirurgen die opgeleid zijn in het Erasmus MC en illustratief voor de kwaliteit 
van betreﬀende opleiding, hartelijk dank voor jullie warmte en collegialiteit.
 
Deskundige thorax anesthesiologie vormt de basis voor een goed operatieresultaat. 
Jan Hoﬂand, Yvon Deryck, Dries van der Woerd, Thierry Scohy, Carsten Preis, Christian 
Lüthen en René Hagenouw dank voor jullie deskundige inbreng en dank voor de samen-
werking.
Aan de intensivisten Ard Struys, Rob van Thiel, Wim Lagrand, Erik Lust, Anne Paling, Dinis 
dos Reis Miranda en Rogier Nieuwendijk. In deze context ook aan Martin van der Ent. 
Allen dank voor de prettige samenwerking en jullie loyaliteit.
De samenwerking met de afdeling Cardiologie en met de “Rijnmond cardiologen” ken-
merkt zich niet alleen door het streven naar hoge medische kwaliteit, maar is ook inter-
collegiaal uiterst aangenaam, zoals vooral blijkt bij gezamenlijk congres bezoek. Hier 
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wordt het nuttige met het aangename gecombineerd. De frequentie van deze gemeen-
schappelijke kennisvergaring is helaas te laag. 
Assistenten, maar ook oud-assistenten, Thoraxchirurgie en Cardiologie dank voor jullie 
interesse, samenwerking  en gezellige momenten.
Mijn professionele ontwikkeling is mede tot stand gekomen door de inbreng van ver-
pleegkundig en faciliterend personeel op de afdelingen MC Thoraxchirurgie, de IC, de 
OK (inclusief ECC en Anesthesiologie), het secretariaat, de onderzoekgroep, de Hartklep-
penbank, de computergroep, het CathLab, MC Cardiologie, de polikliniek Thoraxcen-
trum en afdeling Echocardiologie, waarvoor mijn dank.
Beste Anton,  Koning van de “I-space”, dank voor je stimulerend enthousiasme in het vir-
tueel maken van 3D echocardiograﬁe en je bijdrage aan de cover van dit proefschrift.
Afdeling Algemene Heelkunde in het MCA te Alkmaar dank ik voor de geweldig mooie 
periode gedurende mijn vooropleiding. Een periode van veel plezier, hard werken en 
leveren van goede gezondheidszorg. Ik heb twee jaar een betaalde vakantie genoten!
Nadat ik was uitgeloot voor de studie geneeskunde wilde ik een jaar werken. Ik belandde 
in Restaurant Plaswijck en ben daar 7 jaar later pas gestopt, na het behalen van mijn art-
senbul. Geen betere opleidingsplek dan de horeca, waar  je leert in een team te werken, 
te communiceren en te organiseren. Rob en Cecile van der Valk, dank voor deze inspan-
nende ontspanning.
Het feit dat je broers tevens je beste vrienden zijn is een vorm van rijkdom. René, tevens 
paranimf, en Peter dank voor jullie onvoorwaardelijke steun. Het feit dat een zus onge-
veer deze zelfde “vriendenstatus” heeft is uniek, dank je wel  lieve Nicolette.
Mijn vrienden met wie ik jarenlang veel lief en een beetje leed heb doorgemaakt. Léon 
Boer, Edward Piena en Michel Stok, wellicht weer eens tijd voor een goede reünie?
Mijnheer en mevrouw Lindenburg, lieve oom Piet en tante Lenie, hartelijk dank voor de 
vele momenten dat jullie er voor ons gezin waren. Jullie hebben niet de oﬃciële status 
van grootouders voor onze kinderen, maar zo zien wij jullie wel.
Mijn ouders, en met name mijn moeder als drijvende kracht, maar ook Dervis Kalkan, 
voor de mogelijkheden die ze me boden. Mama, jij bent degene op deze aarde voor wie 
ik het meest respect heb, ik houd van je.
Dankwoord 107
Mijn kinderen, Fleur, Joris en Pieter, vormen het meest dierbare in mijn leven. De trots 
die mij, als jullie vader, vervult is onbeschrijfelijk, warm en vol emotie.  Ineke, mijn “schat-
bewaker”, jij bezit nog steeds de eigenschap om in iedere ruimte en in ieder gezelschap 
warmte en sfeer te creëren. Deze eigenschappen en mijn respect en mijn liefde voor jou 
vormen de basis voor wat jij voor mij betekent. Ik ben trots op je.
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